BBHC (TRNX) 10-K 16 Apr 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Apr. 09, 2018	Jun. 30, 2017
Document And Entity Information
Entity Registrant Name	MAGNEGAS CORP
Entity Central Index Key	1,353,487
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 6,470,040
Entity Common Stock, Shares Outstanding		11,360,153
Trading Symbol	MNGA
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,017

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current Assets
Cash	$ 586,824	$ 1,616,410
Accounts receivable, net	389,652	442,555
Inventory	738,950	1,615,933
Prepaid and other current assets	198,056	226,305
Total Current Assets	1,913,482	3,901,203
Property and equipment, net of accumulated depreciation and amortization of $2,032,265 and $1,474,944, respectively	6,865,389	6,402,931
Deposit on acquisition	325,000
Intangible assets, net of accumulated amortization of $457,171 and $401,277, respectively	412,331	437,121
Security deposits	27,127	26,636
Goodwill	2,108,781	2,108,781
Total Assets	11,652,110	12,876,672
Current Liabilities
Accounts payable	1,716,661	416,247
Accrued expenses	909,562	276,630
Deferred revenue and customer deposits	44,095	25,000
Capital leases payable, current	27,460	9,328
Note payable, net of debt discount of $13,043 and $0, respectively	451,754
Promissory notes payable - related party	100,000
Derivative liabilities		7,700,585
Total Current Liabilities	3,249,532	8,427,790
Long Term Liabilities
Note payable	520,000	520,000
Capital leases payable, net of current portion	63,839	25,317
Senior convertible debenture, net of debt discount of $0 and $811,000, respectively		75,000
Total Liabilities	3,833,371	9,048,107
Common stock: $0.001 par; 190,000,000 shares authorized; 1,782,864 shares issued and outstanding at December 31, 2017 and 386,935 shares issued and outstanding at December 31, 2016	1,783	387
Additional paid-in-capital	71,852,874	57,385,658
Accumulated deficit	(64,582,868)	(53,558,480)
Total Stockholders' Equity	7,272,789	3,828,565
Total Liabilities, Temporary Equity and Stockholders' Equity	11,652,110	12,876,672
Redeemable Convertible Series C Preferred Stock [Member]
Long Term Liabilities
Temporary equity	115,000
Redeemable Convertible Series D Preferred Stock [Member]
Long Term Liabilities
Temporary equity
Redeemable Convertible Series E Preferred Stock [Member]
Long Term Liabilities
Temporary equity	430,950
Series A Preferred Stock [Member]
Long Term Liabilities
Preferred stock: $0.001 par; 10,000,000 shares authorized	1,000	1,000
Series B Preferred Stock [Member]
Long Term Liabilities
Preferred stock: $0.001 par; 10,000,000 shares authorized

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Property and equipment, net of accumulated depreciation and amortization	$ 2,032,265	$ 1,474,944
Intangible assets, net of accumulated amortization	457,171	401,277
Note payable, net of debt discount	13,043	0
Senior convertible debenture, net of debt discount	$ 0	$ 811,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	190,000,000	190,000,000
Common stock, shares issued	1,782,864	386,935
Common stock, shares outstanding	1,782,864	386,935
Redeemable Convertible Series C Preferred Stock [Member]
Temporary equity, shares authorized	25,000	25,000
Temporary equity, shares issued	115	115
Temporary equity, shares outstanding	115	115
Temporary equity, liquidation preference	$ 132,000	$ 0
Redeemable Convertible Series D Preferred Stock [Member]
Temporary equity, shares authorized	694,422	694,422
Temporary equity, shares issued	0	0
Temporary equity, shares outstanding	0	0
Redeemable Convertible Series E Preferred Stock [Member]
Temporary equity, shares authorized	455,882	455,882
Temporary equity, shares issued	402,464	402,464
Temporary equity, shares outstanding	402,464	402,464
Temporary equity, liquidation preference	$ 496,000	$ 0
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000,000	1,000,000
Preferred stock, shares outstanding	1,000,000	1,000,000
Preferred stock, liquidation preference, value
Series B Preferred Stock [Member]
Preferred stock, shares authorized	2,700	2,700
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Revenue:	$ 3,719,452	$ 3,552,245
Cost of Revenues	2,216,773	2,018,453
Gross Profit	1,502,679	1,533,792
Operating Expenses:
Selling, general and administration	11,663,680	10,478,676
Research and development	171,651	678,546
Impairment of joint venture		806,716
(Gain) loss on sale and disposal of property and equipment	(50,180)	1,049,305
Depreciation and amortization	673,062	650,887
Total Operating Expenses	12,458,213	13,664,130
Operating Loss	(10,955,534)	(12,130,338)
Other Income and (Expense):
Interest	(14,684)	(51,687)
Loss on modification of warrants		(2,897,291)
Accretion of debt discount	(1,030,372)	(189,000)
Excess fair value of warrants issued over related debt		(2,622,080)
Other (expense) income	(1,778)	49,842
Loss on extinguishment of debt	(513,725)
Change in fair value of derivative liability	2,255,322	370,626
Loss on settlement of liabilities	(763,617)
Total Other Income (Expense)	(68,854)	(5,339,590)
Net Loss	(11,024,388)	(17,469,928)
Deemed dividend	4,974,182
Net loss attributable to common shareholders	$ (15,998,570)	$ (17,469,928)
Net loss per share: Basic and Diluted	$ (22.22)	$ (52.74)
Weighted average common shares: Basic and Diluted	719,918	331,251

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity - USD ($)	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated (Deficit) [Member]	Total
Balance at Dec. 31, 2015	$ 1,000	$ 304	$ 50,703,512	$ (36,088,552)	$ 14,616,264
Balance, shares at Dec. 31, 2015	1,000,000	303,997
Common stock and warrants issued for cash proceeds, net		$ 7	2,785,280		$ 2,785,287
Common stock and warrants issued for cash proceeds, net, shares		6,803			1,333
Common shares issued for services		$ 11	1,109,489		$ 1,109,500
Common shares issued for services, shares		10,992			10,992
Amortization of stock based compensation			346,906		$ (346,906)
Prefunded warrants issued for cash, net			2,540,821		2,540,821
Reclassification of warrants to derivative liability due to tainting of warrants			(5,396,350)		(5,396,350)
Common shares issued for the exercise of warrants		$ 64	95,650		95,714
Common shares issued for the exercise of warrants, shares		63,810
Reclassification of derivative liability to equity from the exercise of warrants and issuance of shares for convertible debt			5,086,351		5,086,351
Common shares issued for the settlement of debt		$ 1	113,999		114,000
Common shares issued for the settlement of debt, shares		1,333
Conversion of notes into shares of common stock					$ 114,000
Conversion of notes into shares of common stock, shares					1,333
Net loss				(17,469,928)	$ (17,469,928)
Balance at Dec. 31, 2016	$ 1,000	$ 387	57,385,658	(53,558,480)	3,828,565
Balance, shares at Dec. 31, 2016	1,000,000	386,935
Common shares issued for services		$ 204	2,971,261		2,971,465
Common shares issued for services, shares		203,666
Amortization of stock based compensation			425,492		(425,492)
Common shares issued for the exercise of warrants		$ 5	7,932		7,937
Common shares issued for the exercise of warrants, shares		5,291
Common shares issued for the settlement of debt		$ 107	631,862		631,969
Common shares issued for the settlement of debt, shares		106,667
Board of directors fees paid in common stock		$ 47	209,655		209,702
Board of directors fees paid in common stock, shares		46,665
Issuance of common stock and series B preferred stock in accordance with debt extinguishment		$ 7	5,652,493		5,652,500
Issuance of common stock and series B preferred stock in accordance with debt extinguishment, shares		6,667
Issuance of common stock with Series D preferred units		$ 10	131,750		131,760
Issuance of common stock with Series D preferred units, shares		10,000
Conversion of series B preferred stock into common stock		$ 60	(60)
Conversion of series B preferred stock into common stock, shares		60,000
Conversion of Series C preferred stock into common stock		$ 634	3,412,366		3,413,000
Conversion of Series C preferred stock into common stock, shares		634,482
Conversion of Series D preferred stock into common stock		$ 120	694,302		694,422
Conversion of Series D preferred stock into common stock, shares		120,100
Conversion of Series E preferred stock into common stock		$ 36	189,013		189,049
Conversion of Series E preferred stock into common stock, shares		36,010
Conversion of notes into shares of common stock		$ 153	856,847		857,000
Conversion of notes into shares of common stock, shares		153,048
Reclassification of derivative liability to equity			427,568		427,568
Stock issuance costs			(745,367)		(745,367)
Deemed Dividend			(457,801)		(457,801)
Common shares issued for settlement of vendor liabilities		$ 13	59,903		59,916
Common shares issued for settlement of vendor liabilities, shares		13,333
Net loss				(11,024,388)	(11,024,388)
Balance at Dec. 31, 2017	$ 1,000	$ 1,783	$ 71,852,874	$ (64,582,868)	$ 7,272,789
Balance, shares at Dec. 31, 2017	1,000,000	1,782,864

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows from Operations
Net Loss	$ (11,024,388)	$ (17,469,928)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	673,062	650,887
Accretion of debt discount	1,030,372	189,000
Amortization of stock-based compensation	425,492	346,906
Common stock issued for services	2,971,465	1,109,500
Provision for bad debt		36,363
Provision for slow moving spare parts	50,000	175,000
(Gain) loss on sale and disposal of property and equipment	(50,180)	1,049,305
Loss on settlement of debt	751,902
Loss on settlement of vendor liability	11,715
Provision for impairment of investment in joint venture		806,716
Loss on modification of warrants		2,897,291
Excess fair value of warrants over related debt		2,622,080
Loss on extinguishment of debt	513,725
Change in fair value of derivative liability	(2,255,322)	(370,626)
Changes in operating assets:
Accounts receivable	52,903	(105,912)
Inventory	(35,966)	(45,752)
Prepaid and other current assets	28,249	94,126
Accounts payable	1,348,614	(9,047)
Accrued expenses	701,386	(228,225)
Deferred revenue and customer deposits	19,095	(387,500)
Net cash used in operating activities	(4,787,876)	(8,639,816)
Cash Flows from Investing Activities
Deposit on acquisition	(325,000)
Purchase of property and equipment and intangible assets	(250,252)	(1,445,855)
Security deposit	(491)	(2,523)
Investment in joint ventures		(52,115)
Proceeds from sale of assets	121,343	20,450
Net cash used in investing activities	(454,400)	(1,480,043)
Cash Flows from Financing Activities
Capital lease payments	(12,038)	(5,423)
Net proceeds on sale of notes payable	940,000
Principle payments on notes payable	(776,292)	2,785,287
Net proceeds on related party notes and advances	289,173
Related party notes payments	(7,103)
Net proceeds from senior convertible debenture, net		1,000,000
Net proceeds from prefunded warrants, net		2,540,821
Net proceeds from sale and issuance of preferred stock	3,771,013
Cash proceeds from exercise of warrants	7,937	95,714
Net cash provided by financing activities	4,212,690	6,416,400
Net decrease in cash	(1,029,586)	(3,703,459)
Cash, beginning of year	1,616,410	5,319,869
Cash, end of year	586,824	1,616,410
Supplemental disclosure of cash flow information Cash paid during the year for:
Interest
Noncash Transactions
Issuance of common stock for the settlement of senior convertible debentures		114,000
Reclassification of equity instruments to derivative liabilities due to tainting of warrants		(5,396,350)
Reclassification of derivative liabilities to equity from the exercise of warrants and issuance of shares for convertible debt		5,086,351
Issuance of equity instruments attached to senior convertible debentures		1,000,000
Reclassification of derivative liability to equity	(427,568)
Issuance of common stock and series B preferred stock for debt extinguishment	5,652,502
Common shares issued for debt	857,000
Conversion from note payable to convertible note payable	$ 500,000

Organization and Description of

Organization and Description of Business	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Organization and Description of Business	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS MagneGas Corporation (the “Company”) was organized in the State of Delaware on December 9, 2005. The Company is an alternative energy company that creates a system that produces hydrogen based fuel through the gasification of liquid and liquid waste. Management has developed a process which gasifies various types of liquids and liquid wastes through a proprietary plasma arc system. A byproduct of this process is an alternative to natural gas currently sold in the metalworking market as a cutting fuel. The Company produces gas bottled in cylinders for the purpose of distribution to the metalworking market as an alternative to acetylene. Additionally, the Company markets for sale its proprietary plasma arc technology for the processing of liquid waste (the “Plasma Arc Flow Units” or “Plasma Arc Flow System”), is developing ancillary uses of its MagneGas2® fuel for co-combustion and has acquired a gas distribution company that sells various types of industrial fuels and supplies. Through the course of its business development, the Company has established a retail and wholesale platform to sell its fuel for use in the metalworking and manufacturing industries. The Company has also established a network of brokers to sell its Plasma Arc Flow equipment internationally. In October of 2014, the Company purchased Equipment Sales and Services, Inc. (“ESSI”) for $3 million cash. ESSI is a full line seller of industrial gases and equipment for the welding and metal cutting industries. Since acquiring ESSI, the Company has opened three additional retail locations and distributes their proprietary MagneGas2® product as well as other gases and welding supplies through ESSI, the Company’s wholly owned subsidiary. On February 1, 2017, the Company formed two wholly owned subsidiaries in the State of Delaware called MagneGas Energy Solutions, LLC and MagneGas Welding Supply, LLC, respectively. MagneGas Energy Solutions, LLC was formed to acquire another company but the acquisition did not occur, so the Company will be used for future purposes. Magnegas Welding Supply, LLC was formed to be the holding company for all of the Company’s other welding supply companies, ESSI. On March 3, 2017, the Company formed three wholly owned subsidiaries in the State of Delaware called MagneGas Real Estate Holdings, LLC, MagneGas IP, LLC and MagneGas Production, LLC, respectively. Magnegas Real Estate Holdings, LLC was formed to hold all future real estate for risk management purposes. Magnegas IP, LLC was formed to be the company that holds all of the consolidated entity’s intellectual property and Magnegas Production, LLC is the company where the gas is actually produced. Operating segments are defined as components of an enterprise about which separate financial information is available and that is evaluated regularly by the chief operating decision maker, or decision–making group in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is the Chief Executive Officer. The Company discusses three major marketing initiatives below. Even though the Company discusses discrete initiatives it is actually three product offerings within one operating segment.

Going Concern and Managements'

Going Concern and Managements' Plan	12 Months Ended
	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern and Managements' Plan	NOTE 2 - GOING CONCERN AND MANAGEMENTS’ PLAN As of December 31, 2017, the Company had cash of $586,824 and has reported a net loss of $11,024,388 and has used cash in operations of $5,112,876 for the year ended December 31, 2017. In addition, as of December 31, 2017 the Company has a working capital deficit of $1,336,050 and an accumulated deficit of $64,582,868. The Company utilizes cash in its operations of approximately $430,000 per month. These conditions indicate that there is substantial doubt about the Company’s ability to continue as a going concern within one year from the issuance date of the financial statements. The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering. Historically, the Company has financed its operations through equity and debt financing transactions and expects to continue incurring operating losses for the foreseeable future. The Company’s plans and expectations for the next 12 months include raising additional capital to help fund expansion of its commercial operations, including product development. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset amounts or the classification of liabilities that might be necessary should the Company be unable to continue as a going concern. If these sources do not provide the capital necessary to fund the Company’s operations during the next twelve months from the date of this report, the Company may need to curtail certain aspects of its operations or expansion activities, consider the sale of its assets, or consider other means of financing. The Company can give no assurance that it will be successful in implementing its business plan and obtaining financing on terms advantageous to the Company or that any such additional financing would be available to the Company. These consolidated financial statements do not include any adjustments from this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The Company prepares its financial statements in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The consolidated financial statements presented include inventory reserves, fair value of derivative financial instruments, recoverability of deferred tax assets and collections of its receivables. Concentrations of Credit Risk The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation (“FDIC”). At times, the Company may have deposits in excess of federally insured limits. Cash and Cash Equivalents Cash and cash equivalents consist of cash, checking accounts, money market accounts and temporary investments with original maturities of three months or less when purchased. As of December 31, 2017, and 2016 the Company had no cash equivalents. Accounts Receivable Accounts receivable consist of amounts due for the delivery of MagneGas2® sales to customers with payment terms of generally 30 days. An allowance for doubtful accounts is established for any amounts that may not be recoverable, which is based on an analysis of the Company’s customer credit worthiness, historical estimates, and current economic trends. Receivables are determined to be past due, based on payment terms of original invoices. The Company does not typically charge interest on past due receivables. The allowance for doubtful accounts was $101,063 and $145,931 for the years ended December 31, 2017 and 2016, respectively. Inventory Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. Inventory is comprised of spare parts; consumables used in the production of gas, regulators and tips and work in process. Estimates of lower of cost or net realizable value are based upon economic conditions, historical sales quantities and patterns, and in some cases, the specific risk of loss on specifically identified inventories. The Company evaluates inventories on a regular basis to identify inventory on hand that may be slow moving. Inventory that is in excess of current and projected use is reduced by an allowance to the level that approximates its estimate of future demand. In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”). ASU 201-11 requires that inventory measured using any method other than last-in, first out (“LIFO”) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market value. Under this ASU, subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. ASU 2015-11 is effective prospectively for fiscal years, and for interim periods within those years, beginning after December 15, 2016. We adopted this standard effective January 1, 2017. The adoption of this standard did not have a material impact on our consolidated financial statements. Property and equipment, net Property and equipment are stated at cost net of accumulated depreciation using the straight–line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which range from three to thirty-nine and a half years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures which extend the economic life are capitalized. When assets are retired, or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized. Intangible assets, net The Company’s recorded intangible assets consist of intellectual property. Applicable long–lived assets are amortized or depreciated over the shorter of their estimated useful lives, the estimated period that the assets will generate revenue, or the statutory or contractual term. Estimates of useful lives and periods of expected revenue generation are reviewed periodically for appropriateness and are based upon management’s judgment. Intangible assets are amortized on the straight-line method over their useful lives of 15 years. Goodwill and Other Indefinite-lived Assets The Company records goodwill and other indefinite-lived assets in connection with business combinations. Goodwill, which represents the excess of acquisition cost over the fair value of the net tangible and intangible assets of acquired companies, is not amortized. Indefinite-lived assets are stated at fair value as of the date acquired in a business combination. The Company assesses the recoverability of goodwill and certain indefinite-lived intangible assets annually in the fourth quarter and between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is done at a reporting unit level. Under Financial Accounting Standards Board (“FASB”) guidance for goodwill and intangible assets, a reporting unit is defined as an operating segment or one level below the operating segment, called a component. However, two or more components of an operating segment will be aggregated and deemed a single reporting unit if the components have similar economic characteristics. The Company operates as one reporting unit. Authoritative accounting guidance allows the Company to first assess qualitative factors to determine whether it is necessary to perform the more detailed two-step quantitative goodwill impairment test. The Company performs the quantitative test if its qualitative assessment determined it is more likely than not that a reporting unit’s fair value is less than its carrying amount. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test for any reporting unit or asset. The quantitative goodwill impairment test, if necessary, is a two-step process. The first step is to identify the existence of a potential impairment by comparing the fair value of a reporting unit (the estimated fair value of a reporting unit is calculated using a discounted cash flow model) with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, the reporting unit’s goodwill is considered not to be impaired and performance of the second step of the quantitative goodwill impairment test is unnecessary. However, if the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss to be recorded, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit’s goodwill exceeds its implied fair value, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined using the same approach as employed when determining the amount of goodwill that would be recognized in a business combination. That is, the fair value of the reporting unit is allocated to all of its assets and liabilities as if the reporting unit had been acquired in a business combination and the fair value was the purchase price paid to acquire the reporting unit. For the 2017 annual goodwill and certain indefinite-lived intangible assets impairment tests, the Company elected to bypass the qualitative assessment and proceeded directly to the quantitative analysis using the market price of the stock and determined that no impairment was deemed to exist as of December 31, 2017. Impairment of Long-Lived Assets The Company assesses the recoverability of its long-lived assets, including property and equipment, when there are indications that the assets might be impaired. When evaluating assets for potential impairment, the Company compares the carrying value of the asset to its estimated undiscounted future cash flows. If an asset’s carrying value exceeds such estimated undiscounted cash flows, the Company records an impairment charge for the difference between the carrying amount of the asset and its fair value. Based on its assessments, the Company did not record any impairment charges for the year ended December 31, 2017 and recorded an impairment charge of $806,716 for the year ended December 31, 2016. Revenue Recognition The Company generates revenue through three processes: (1) the sale of its MagneGas2® fuel for metal cutting and (2) the sale of its Plasma Arc Flow Units. Additionally, and (3) the Company also recognizes revenue from territorial license arrangements, and through the sales of metal cutting gases and related products through their wholly owned subsidiary, ESSI. ● Revenue for metal-working fuel and related products are recognized when shipments are made to customers. The Company recognizes a sale when the fuel and/or product has been shipped and risk of loss has passed to the customer and collectability is reasonably assured. Cylinder rentals are billed on a monthly basis. ● Revenue generated from sales of each Plasma Arc Flow Unit is recognized upon delivery. Significant deposits are required before production commences. These deposits are classified as customer deposits. ● Licenses are issued, per contractual agreement, for distribution rights within certain geographic territories. The Company recognizes revenue ratably, based on the amounts paid or values received, over the term of the licensing agreement. The Company, on occasion, may recognize revenue under a bill-and-hold arrangement. Under a bill-and-hold arrangement revenue is recognized when the product is manufactured, completed, invoiced and segregated from the seller’s other inventory so that it is not subjected to being used to fill other orders. Upon invoicing under this arrangement, ownership has passed to the buyer with no right of return such that the earnings process is complete. The customer must request a bill-and-hold arrangement (preferably in writing), must commit to the purchase and the delivery date must be fixed. During the year ended December 31, 2016, the Company recognized $775,000 of revenues under this arrangement. The Company also enters into sales transactions whereby customer orders contain multiple deliverables and reports its multiple deliverable arrangements under ASC 605-25 “Revenue Arrangements with Multiple Deliverables” (“ASC-605-25”). These multiple deliverable arrangements primarily consist of the following deliverables: the Company’s MagneGas units, design, configuration, installation and training services. In situations where the Company bundles all or a portion of the separate elements, Vendor Specific Objective Evidence (“VSOE”) is determined based on prices when sold separately. For the years ended December 31, 2017 and 2016, multiple deliverable arrangements were immaterial. Preferred Stock The Company applies the accounting standards for distinguishing liabilities from equity under U.S. GAAP when determining the classification and measurement of its Preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred shares are classified as permanent equity. Derivative Liability The Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification 815-10-05-4 and 815-40-25. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date. The Company had no derivative liabilities as of December 31, 2017 and derivative liabilities of $7,700,585 at December 31, 2016. Beneficial conversion feature of convertible notes payable The Company accounts for convertible notes payable in accordance with the guidelines established by the FASB Accounting Standards Update (“ASU”) Topic 470-20, Debt with Conversion and Other Options. The beneficial conversion feature of a convertible note is normally characterized as the convertible portion or feature of certain notes payable that provide a rate of conversion that is below market value or in-the-money when issued. The Company records a beneficial conversion feature related to the issuance of a convertible note when issued and also records the estimated fair value of any warrants issued with those convertible notes. The beneficial conversion features that are contingent upon the occurrence of a future event are recorded when the contingency is resolved. The effective conversion price and the market price of the Company’s common stock are used to calculate the intrinsic value of the conversion feature. The intrinsic value is recorded in the financial statements as a debt discount from the face amount of the note and such discount is amortized over the expected term of the convertible note (or to the conversion date of the note, if sooner) and is charged to interest expense. Advertising Costs The costs of advertising are expensed as incurred. Advertising expenses are included in the Company’s operating expenses. Advertising expense was $4,218 and $110,755 for the years ended December 31, 2017 and 2016, respectively. Research and Development The Company expenses research and development costs when incurred. Research and development costs include engineering and laboratory testing of product and outputs. Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of Accounting Standards Codification 718, “Compensation—Stock Compensation” (“ASC 718”), which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or canceled during the periods reported. The Company incurred stock-based compensation charges, net of estimated forfeitures of $425,492 and $346,906 for the year ended December 31, 2017 and 2016, respectively and has included such amounts in selling, general and administrative expenses in the consolidated statements of operations. Stock-Based Compensation for Non-Employees The Company accounts for warrants and options issued to non-employees under Accounting Standards Codification 505-50, “Equity – Equity Based Payments to Non-Employees”, using the Black-Scholes option-pricing model. The value of such non-employee awards unvested are re-measured over the vesting terms at each reporting date. Warranty Liabilities The Company accrues an estimate of their exposure to warranty claims based on both current and historical product sales data and warranty costs incurred. The majority of the Company’s products carry a 1-year parts and labor warranty. Additional components carry a warranty from their own manufacturers. All such warranty details will be passed from Manufacturer to Buyer on or before delivery. The Company assesses the adequacy of their recorded warranty liability annually and adjusts the amount as necessary. As of December 31, 2017 and 2016, the accrued warranty liability was deemed to be immaterial. Income Taxes The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized. The Company is subject to examination by U.S. tax authorities beginning with December 31, 2014. On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Reform Bill”) was signed into law. Prior to the enactment of the Tax Reform Bill, the Company measured its deferred tax assets at the federal rate of 34%. The Tax Reform Bill reduced the federal tax rate to 21% resulting in the re-measurement of the deferred tax asset as of December 31, 2017. Beginning January 1, 2018, the lower tax rate of 21% will be used to calculate the amount of any federal income tax due on taxable income earned during 2018. Basic and Diluted Net (Loss) per Common Share Basic (loss) per common share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding for each period. Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding plus the dilutive effect of shares issuable through the common stock equivalents. As of December 31, 2017, and 2016 the Company’s common stock equivalents outstanding. December 31, 2017 2016 Options 15,340 31,530 Common Stock Warrants 222,222 155,108 Convertible preferred stock 147,901 - Convertible secured debentures - 11,696 Total common stock equivalents outstanding 385,463 198,334 Recent Accounting Standards Revenue Related Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers,” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 — Revenue Recognition and most industry-specific guidance throughout the ASC. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. To allow entities additional time to implement systems, gather data and resolve implementation questions, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, in August 2015, to defer the effective date of ASU No. 2014-09 for one year, which is fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact of the adoption of ASU 2014-09 on its financial statements or disclosures. In addition, the FASB issued ASU 2016-08 in March 2016, to help provide interpretive clarifications on the new guidance in ASC Topic 606. The Company is currently evaluating the accounting, transition, and disclosure requirements of the standard to determine the impact, if any, on its financial statements. In March 2016, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers—Principal versus Agent Considerations.” This update provides clarifying guidance regarding the application of ASU No. 2014-09 — Revenue from Contracts with Customers when another party, along with the reporting entity, is involved in providing a good or a service to a customer. In these circumstances, an entity is required to determine whether the nature of its promise is to provide that good or service to the customer (that is, the entity is a principal) or to arrange for the good or service to be provided to the customer by the other party (that is, the entity is an agent). The amendments in the Update clarify the implementation guidance on principal versus agent considerations. The update is effective, along with ASU 2014-09, for annual and interim periods beginning after December 15, 2017. ASU 2016-08 is not expected to have a material impact on the financial statements or disclosures. On May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2016-12”). ASU 2016-12 provides clarifying guidance in a few narrow areas and adds some practical expedients to the guidance. The effective date and transition requirements for this ASU are the same as the effective date and transition requirements for ASU 2014-09. The Company is evaluating the effect of ASU 2014-09, if any, on its financial statements. In September 2017, the FASB issued ASU No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments” that enhances the guidance surrounding sale leaseback transactions, accounting for taxes on leveraged leases and leases with third party value. The related amendments to the Topics described above become effective on the same schedule as Topics 605, 606, 840 and 842. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of relief from certain reporting requirements and other burdens that are otherwise applicable generally to public companies. These provisions include an exemption from the adoption of new or revised financial accounting standards until they would apply to private companies. As such, the Company has delayed the adoption of Accounting Standards Codification (“ASC”) No. 606, Revenue from Contracts with Customers until January 1, 2019. Other Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which addresses the diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows with respect to eight specific cash flow issues. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The amendments should be applied using a retrospective transition method to each period presented, if practical. Early adoption is permitted, including the interim period, and any adjustments should be reflected as of the beginning of the fiscal period. ASU 2016-15 is not expected to have a material impact on the financial statements or disclosures. In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory”, In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230)” In May 2017, the FASB issued ASU 2017-09, “ Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting,” In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”. Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company has adopted the accounting guidance. The adoption of this ASU resulted in the Company reclassifying $427,568 representing the fair value of the derivative liability on the date of the exchange to stockholders’ equity. Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements, except as disclosed in Note 15.

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Fair Value	NOTE 4 – FAIR VALUE Accounting Standards Codification 820, “Fair Value Measurements and Disclosure,” (“ASC 820”) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels are described below: Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company; Level 2 Inputs – Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly; Level 3 Inputs – Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants. The carrying amount of the Company’s financial assets and liabilities, such as cash, accounts payable, accrued expenses and notes payable approximate their fair value because of the short maturity of those instruments. Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to those that prevail in arm’s-length transactions unless such representations can be substantiated. Impairment. The carrying value of the Company’s joint ventures and other long-lived assets are tested for impairment annually, at the end of the fourth quarter of each fiscal year, and between annual tests if an event occurs or circumstances change that would indicate it is more likely than not that the carrying amount may be impaired. Additionally, the Company continually evaluates whether events or changes in circumstances might indicate that the remaining estimated useful life of long-lived assets may warrant revision, or that the remaining balance may not be recoverable. The factors used to determine fair value are subject to management’s judgement and expertise and include, but are not limited to, the present value of future cash flows, net of estimated operating costs, internal forecasts, anticipated capital expenditures and various discount rates commensurate with the risk and current market conditions associated with realizing the expected cash flows projected. These assumptions represent Level 3 inputs. There were no impairment charges during the year ended December 31, 2017. Impairment of the Company’s joint ventures for the year ended December 31, 2016 was $806,719. The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following tables provides a summary of financial instruments that are measured at fair value as of December 31, 2017 and December 31, 2016, respectively. December 31, 2017 Quoted Prices In Active Significant Markets for Other Significant Identical Observable Unobservable Liabilities Inputs Inputs Total (Level 1) (Level 2) (Level 3) Warrant liability $ — — — $ — Embedded conversion feature — — — — Derivative liability – December 31, 2017 $ — — — $ — December 31, 2016 Quoted Prices In Active Significant Markets for Other Significant Identical Observable Unobservable Liabilities Inputs Inputs Total (Level 1) (Level 2) (Level 3) Warrant liability $ 7,195,617 — — $ 7,195,617 Embedded conversion feature 504,968 — — 504,968 Derivative liability – December 31, 2016 $ 7,700,585 — — $ 7,700,585 The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2017 and 2016: Embedded Total Warrant Conversion Derivative Liability Feature Liabilities Balance – December 31, 2015 $ 1,241,841 $ - $ 1,241,841 Change in fair value (386,182 ) 15,556 (370,626 ) Warrants issued in connection with debt transactions 446,588 553,412 1,000,000 Loss on modification of warrants 2,622,080 Excess fair value of warrants issued over related debt 2,879,291 - 5,591,371 Reclassification of equity instruments to derivative liabilities due to tainting of warrants 5,396,350 - 5,396,350 Reclassification of derivative liabilities to equity from the exercise of warrants and issuance of shares for convertible debt (5,022,351 ) (64,000 ) 5,086,351 ) Balance – December 31, 2016 7,195,617 504,968 7,700,585 Change in fair value (2,131,990 ) (123,332 ) (2,255,322 ) Reclassification of derivative liabilities to equity (396,854 ) (30,714 ) (427,568 ) Derivative extinguishment (4,666,773 ) (350,922 ) (5,017,695 ) Balance – December 31, 2017 $ — $ — $ — The Company’s Level 3 liabilities shown in the above table consist of warrants that contain a cashless exercise feature that provides for their net share settlement at the option of the holder. In addition, the convertible debt conversion feature has a price reset provision with no floor. The warrants also contain a fundamental transaction provision that permits their settlement in cash at fair value at the option of the holder upon the occurrence of a change in control. Such change in control events include tender offers or hostile takeovers, which are not within the sole control of the Company as the issuer of these warrants. Settlement at fair value upon the occurrence of a fundamental transaction computed using the Black Scholes Option Pricing Model using the following assumptions: Assumptions utilized in the valuation of Level 3 liabilities are described as follows: For the year ended December 31, 2017 2016 Risk free interest rate 0.2%-1.94 % 0.2%-2.25 % Expected term 0.25 to 7.07 years 0.25 to 7.25 years Volatility 62% to 142 % 51 to 123 % Dividends $ 0 $ 0 The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. The expected term used is the contractual life of the instrument being valued. Volatility was calculated using the Company’s historical common stock price over the expected term of the instruments valued. Dividends were deemed to be $0 as the Company has historically never declared any dividends to its stock holders.

Inventory, Net

Inventory, Net	12 Months Ended
	Dec. 31, 2017
Inventory Disclosure [Abstract]
Inventory, Net	NOTE 5 - INVENTORY, NET Inventory primarily consists of: December 31, 2017 December 31, 2016 Production materials consumables, spare parts, and accessories $ 738,950 $ 937,133 Work in process - 853,800 Total at cost 738,950 1,790,933 Slow moving inventory allowance - (175,000 ) Inventory, net $ 738,950 $ 1,615,933

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	NOTE 6 – PROPERTY AND EQUIPMENT, NET Estimated useful life December 31, 2017 December 31, 2016 Machinery and equipment 3 – 5 years $ 482,263 $ 400,106 Furniture and office equipment 5 – 7 years 182,305 179,206 Transportation 3 – 5 years 222,144 303,826 Production units 5 – 30 years 4,910,736 4,757,896 Building 39.5 years 2,237,257 2,236,841 Parts n/a 862,949 - 8,897,654 7,877,875 Accumulated depreciation and amortization (2,032,265 ) (1,474,944 ) $ 6,865,389 $ 6,402,931 Depreciation expense was $616,480 and $599,992 for the years ended December 31, 2017 and 2016, respectively. During the year ended December 31, 2017, the Company ceased selling its older equipment and reclassified its parts inventory to property and equipment. During the year ended December 31, 2016, the Company put in production one unit with an approximate cost of $631,000. During the year ended December 31, 2016, the Company moved its operational facilities and sold and disposed of property and equipment and recorded a charge of approximately $1,049,000.

Intangible Assets, Net

Intangible Assets, Net	12 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets, Net	NOTE 7 – INTANGIBLE ASSETS, NET The Company’s intangible assets consisted of the following: Estimated useful life December 31, 2017 December 31, 2016 Intellectual property 15 years $ 869,502 $ 838,398 Less: Accumulated amortization (457,171 ) (401,277 ) Intangible assets, net $ 412,331 $ 437,121 The Company recorded amortization expense of $55,894 and $55,895 for the year ended December 31, 2017 and 2016, respectively. The following table outlines estimated future annual amortization expense for the next five years and thereafter: December 31, 2018 $ 58,014 2019 58,014 2020 58,014 2021 58,014 2022 58,014 Thereafter 122,261 Total $ 412,331

Investments in Joint Ventures

Investments in Joint Ventures	12 Months Ended
	Dec. 31, 2017
Equity Method Investments and Joint Ventures [Abstract]
Investments in Joint Ventures	NOTE 8 – INVESTMENTS IN JOINT VENTURES The Company’s investment in joint ventures consisted of the following: Magnegas Europe $ 23,750 Magnegas China 466,660 Future Energy PTY, LTD 229,840 Other 34,351 Balance -December 31, 2015 754,601 Additional investments during 2016 52,115 806,716 Less impairment (806,716 ) Balance- December 31, 2016 and 2017, respectively - On June 25, 2010, the Company entered into agreement with a Belgian company, whereby 250,000 shares of the Company’s common stock and territorial license rights were exchanged for a 20% interest in MagneGas Europe. The Company valued the shares issued at the fair value of the shares issued ($23,750). The Company determined it did not have effective or beneficial control of the European entity and the Company accounts for this investment using the equity method. Equity in earnings or loss from MagneGas Europe to date have not been material. The Company has not seen any development of the venture to support the carrying value of the investment and accordingly has recognized an impairment for the full carrying value of the investment. On June 28, 2010, the Company entered into an agreement with DDI Industries, a Chinese company, in contemplation of the formation of MagneGas China. The Company provided mechanical drawings (for complete construction), computer programs, license of patents (Greater China Region), trademarks, among other items of the Plasma Arc Flow Recyclers to the joint venture for a 20% interest in MagneGas China. The fair value of the consideration provided was $466,660. The Company determined it did not have effective or beneficial control over the joint entity and accounts for this investment under the equity method. In May of 2016, the original majority owner of the entity, DDI Industries, sold their interest to another entity, Paishi Environment Technologies, also a Chinese entity. Based on the sales price DDI Industries received in the transaction for its controlling interest and the lack of earnings in the joint venture to date, the Company determined the carrying value of the investment was fully impaired. On March 19, 2014, the Company signed a joint venture agreement with FutureEnergy Pty Ltd of Australia. Under the terms of the agreement, both parties will own 50% of a new company formed for the purpose of developing, licensing and commercializing new intellectual property for co-combustion of MagneGas fuels with hydrocarbon fuels to reduce emissions and increase energy. This agreement includes and extends beyond the existing partnership of coal co-combustion to include other current and future developments such as the combustion of MagneGas with diesel, heavy oil, aviation fuels, and liquid petroleum gas. The fair value of the Company’s investment was $254,840 and is accounted for under the equity method since day to day control rests with the other partners. This joint venture is a development stage company conducting research and development and research activity and has been minimal to date. During the year ended December 31, 2016 the Company had not seen the development of the venture to support the carrying value of the investment so the Company accordingly has recognized an impairment.

Capitalized Leases

Capitalized Leases	12 Months Ended
	Dec. 31, 2017
Leases [Abstract]
Capitalized Leases	NOTE 9 - CAPITALIZED LEASES The Company has equipment under various capital leases expiring in July 2020, October 2020, August 2022 and September 2022. The assets and liabilities under the capital lease are recorded at the lower of the present value of the minimum lease payments or the fair value of the assets. The assets, with costs of approximately $91,299 and $34,645 as of December 31, 2017 and 2016, accumulated amortization of approximately $22,725 and $11,036 as of December 31, 2017 and 2016, respectively, are included in machinery and equipment, and are amortized over the estimated lives of the assets. Amortization of assets under capital leases is included in depreciation expense. At December 31, 2017, annual minimum future lease payments under this capital lease are as follows: For the year ending December 31, Amount 2018 27,460 2019 27,460 2020 24,791 2021 18,132 2022 5,064 Total minimum lease payments 102,907 Less amount representing interest 11,608 Present value of minimum lease payments 91,299 Less current portion of minimum lease 27,460 Long-term present value of minimum lease payment $ 63,839 The interest rate on the capitalized lease is approximately 6% and is imputed based on the lower of the Company’s incremental borrowings rate at the inception of each lease or the lessor’s implicit rate of return.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Notes Payable	NOTE 10 – NOTES PAYABLE Notes Payable – Related Parties On April 3, 2017, the Company entered into a $50,000 promissory note with a member of the Board of Directors. The note bears interest of 15% as is due on July 3, 2017. As of December 31, 2017, the Note has not been repaid. During the first quarter of 2018 the company repaid $35,000 in principal and $6,313 in interest. On April 11, 2017, the Company entered into a $50,000 promissory note with the Company’s Chief Executive Officer (“CEO”). The note bears interest of 15% and was due on July 11, 2017. The CEO funded an additional $7,103 which was repaid as of August 21, 2017. As of December 31, 2017, the Note has not been repaid. During the first quarter of 2018 the company repaid $20,000 in principal and $6,146 in interest. Accrued Expenses – Related Parties During the period July 1, 2017 through December 31, 2017, the CEO, excluding the notes described above, continued to fund working capital in the amount of $249,570. There is no formal note agreement, stated interest rate or maturity date and is payable on demand. As of December 31, 2017, $182,070 is payable to the CEO and is included in accrued expenses. Interest on the aforementioned notes and advances were not material during the year ended December 31, 2017. Senior Convertible Debenture Payable On June 27, 2016, the Company issued and sold a senior convertible debenture that matures in June 2021 in the principal amount of $1,000,000. The debenture has a stated conversion price of $85.50 per share and a stated interest rate of 0.0% per annum. The conversion feature to the note carries a reset provision whereby if the Company enters into a subsequent financing at a price less than the original conversion price the stated conversion price would reset to the lower of the subsequent financing transaction. The holder of the debenture will not have the right to convert any portion of the debenture if the holder, together with its affiliates, would beneficially own in excess of 9.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to such conversion. In connection with the debenture the Company granted the following warrants to purchase common stock of the Company to the investor as follows: Common stock Exercise Expiration Warrants Price Date 23,392 $ 157.50 12/23/2023 11,696 $ 195.00 12/23/2023 46,784 $ 151.50 12/31/2016 23,392 $ 157.50 12/27/2023 11,696 $ 195.00 12/27/2023 In addition, the Company sold to the investor prefunded warrants to purchase 35,088 shares of common stock at an exercise price of $1.50 per share for total cash proceeds of approximately $2,540,821, net of offering costs. The warrant has life of 0.5 years and was fully vested on the date of the grant. The Company also entered into a registration rights agreement whereby the Company is required to maintain an effective registration statement covering the entire common stock equivalent for the conversion of the note and for the common stock issuable for the exercise of the warrants. Under the terms of the registration statement rights agreement the Company is required to have registered shares available for the settlement of these instruments 60 days from the date of the transaction, in the event of a full review the date will be 100 days from the date of the transaction. Should the Company not meet this obligation the Company would be required to pay liquidating damages of 2% of the total investment or approximately $80,000 on the date of the event and every month thereafter until the violation has been cured. The registration statement registering such shares was deemed effective on August 12, 2016. As of December 31, 2016, the Company has not accrued any amount for this contingency as it was deemed not probable that the Company would incur any liquidating damages in connection with the registration rights agreement. In addition, the Company’s wholly owned subsidiary signed a guarantee in connection with the issuance of the debenture and registration rights agreement. The Company has accounted for this transaction under ASC 815 “Derivatives and Hedging” whereby the conversion feature in the debenture was deemed to have a “down round” price protection features with no floor. This feature resulted in the determination that the Company would not have sufficient authorized shares available to settle its outstanding warrants and convertible instruments. As a result of entering into a convertible credit facility for which such instruments contained a variable conversion feature with no floor, the Company has adopted a sequencing policy in accordance with ASC 815-40-35-12 whereby all future instruments may be classified as a derivative liability with the exception of instruments related to share-based compensation. Accordingly, the warrants and the embedded conversion option of the debenture are recorded as derivative liabilities at their fair market value and are required to be marked to market through earnings at the end of each reporting period. The fair value of the financial instruments was determined using the Black-Scholes valuation model which approximated the binomial lattice model. The gross proceeds of the prefunded warrant and the sale of the debenture was recorded net of a discount of $1,000.000. The total fair value of all of the embedded conversion feature and warrants was approximately $6,675,000 which was in excess of the total proceeds of the transaction. The excess fair value of approximately $2,622,080 was recorded as a charge to the consolidated statement of operations as a component of interest expense. The company recorded a charge of approximately $189,000 for the amortization of the debt discount for the year ended December 31, 2016. During the year ended December 31, 2016 1,333 shares of common stock were issued for the settlement of 134,000 of principal reducing the principal amount to $886,000. During the period January 1, 2017 through May 9, 2017 the Company issued 6,667 shares of common stock for the settlement of $57,000 of principal. On May 9, 2017 the Company agreed to amend the terms of a the convertible debenture, which had a current outstanding principal amount of $829,000 on the date of the amendment, as follows: (i) the Conversion Price of the Convertible Debenture is reduced from $85.50 to $45.00, subject to adjustment under the Exchange Agreement or under the terms of such Convertible Debenture, which will result in an increase of 8,726 shares of Common Stock that may be issuable upon conversion of the Convertible Debenture and (ii) the Company shall be permitted to prepay the then-outstanding principal amount of the Convertible Debenture, together with a prepayment premium in the amount of 10% of the principal amount being prepaid. The Company assessed the exchange for extinguishment versus modification accounting. The Company evaluated the fair value of the instrument prior to the exchange and compared such value to the fair value of the consideration received. Because the fair value of the consideration received was greater than 10%, the Company applied extinguishment accounting, resulting in an extinguishment loss of $513,725, which was recorded in other income/expense. On the date of the extinguishment the Company recorded a debt discount of $829,000 which represented the face value of the debt for the beneficial conversion feature associated with the debt. The debt discount will be accreted over the remaining maturity of the note using the straight-line method which approximates the interest rate method. In addition, during the year ended December 31, 2017, the Company adopted ASU 2017-11 which simplified the accounting for certain financial instruments with down round features and accordingly upon the adoption of this standard the derivative liability embedded in the convertible note ceased to exist; accordingly the Company reclassified $427,568 representing the fair value of the derivative liability on the date of the exchange to stockholders’ equity. During the period ended May 9, 2017 through December 31, 2017, the noteholder converted $800,000 in principal into 152,381 shares of the Company’s common stock. On November 30, 2017 the Company entered into a settlement agreement with the noteholder and issued 106,667 shares of common stock for the settlement of $29,000. The excess fair value of the principal amount of $602,970 was recorded as a charge to operation and included as a component in settlement of vendor liability. As of December 31, 2017, the Senior Debentures was repaid in full. As a result of the conversions and settlement agreement, the Company fully accreted the $829,000 in debt discount to other income and expenses for the year ended December 31, 2017. Senior Debentures: On May 9, 2017, the Company entered into an agreement with an institutional investor providing for the sale and issuance of 8% Senior Debentures for gross proceeds of $1,000,000. The debenture was due in November 2017 and bears interest at a rate of 8% per annum. The Company is required to make interest payments quarterly beginning on the original issuance date of the Debenture. The Debenture is unsecured and is not convertible. The Company recognized issuance costs of $60,000 as a debt discount and will expense over the maturity of the note. During the year ended December 31, 2017, the Company recorded an expense of $60,000 for the accretion of the debt discount. Note Agreement On November 15, 2017, the Company entered into a settlement agreement with the holder of the senior debenture and entered into a short-term note agreement having an implicit interest rate of 25% and received net proceeds of $500,000. The short-term note agreement has a term of twelve (12) months and requires the Company to make monthly payments in the amount of $10,416.67 with a $625,000 balloon payment at end of term, which includes a $125,000 commitment fee. The Company has the right prepay the amounts owed under the note at any time without penalty. The Company recorded $250,000 in commitment fees, buy back premiums and interest as an original issue discount and recorded a face amount of $750,000. The $250,000 in discount is being accreted over the 12-month life of the agreement using the straight-line method, which approximates the interest rate method. As of December 31, 2107, the Company accreted $65,796 of the discount. The short term note agreement has a blanket lien on the Company’s assets. The Company recognized a loss on the settlement of the senior debenture of $ 121,428 for the year ended December 31, 2017.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Stockholders' Equity	NOTE 11 - STOCKHOLDERS’ EQUITY Reverse Stock Splits On May 18, 2017, the Company filed an amendment to the Certificate of Incorporation to effect a one-for-ten reverse split of the Company’s issued and outstanding common stock which was effectuated on May 19, 2017. On January 16, 2018, the Company filed an amendment to the Certificate of Incorporation to effect a one-for-fifteen reverse split of the Company’s issued and outstanding common stock which was effectuated on January 16, 2018. The reverse stock splits did not modify the rights or preferences of the common stock. Proportional adjustments have been made to the conversion and exercise prices of the Company’s outstanding common stock warrants, convertible notes, common stock options, and to the number of common stock shares issued and issuable under the Company’s equity compensation plan. The Company did not issue any fractional shares in connection with the reverse stock splits or change the par value per share. Fractional shares issuable entitle shareholders, to receive a cash payment in lieu of the fractional shares without interest. All share and per share amounts for the common stock have been retroactively restated to give effect to the reverse splits. All share and per share amounts for the common stock have been retroactively restated to give effect to the reverse splits. Amendment to Authorized Shares On June 14, 2017, the Company filed an amendment to the Certificate of Incorporation to increase the number of authorized shares of common stock from ninety million (90,000,000) to one hundred ninety million (190,000,000). The proposal for the amendment was approved by the Company’s shareholders at a Special Meeting of Shareholders held on May 17, 2017. Common Stock Issued for Cash During the year ended December 31, 2016 the Company issued 6,803 shares of common stock and 5,291 of pre-funded warrants for net cash proceeds of $2,785,287. The warrants were fully vested on the date of the grant, have a life of 1 year and are exercisable at a $1.50 per share and have a cashless exercise provision. As of December 31, 2016, in connection with the convertible debt issued with a reset provision that contained no floor the Company could not determine it had sufficient authorized shares to settle this contract. Accordingly, the Company reclassified $7,195,617 of fair value of these warrants as a component of derivative liabilities. Common shares issued for services During the year ended December 31, 2017, the Company issued 250,331 shares of the Company’s common stock to key advisors, directors and consultants of the Company. These shares were fully vested on the date of issuance and the fair value of these issuances was $3,181,167. The Company issued 10,992 shares of common stock to consultants for various services rendered during the year ended December 31, 2016. These shares were fully vested on the date of issuance and the fair value of these issuances was $1,109,500. Common shares issued for settlement of liabilities During the year ended December 31, 2017 the Company issued 13,333 of common stock to settle outstanding vendor liabilities of $48,201. In connection with this transaction the company also recorded a loss on settlement of liabilities of $11,715. During the year ended December 31, 2017 the Company issued 106,667 of common stock to settle outstanding debt of $29,000. In connection with this transaction the company also recorded a loss on settlement of liabilities of $631,970, which represents the excess fair value of the shares issued. Common Stock Issued for Exercise of Warrants During the year ended December 31, 2017 the Company issued 5,291 shares of common stock for the exercise of warrants, cash proceeds were $7,937. The exercise of these warrants resulted in a reclassification of the derivative liability associated with these warrants of $396,854, which has been reclassified from derivative liability to stockholders’ equity. During the year ended December 31, 2016 the Company issued 63,810 shares of common stock for the exercise of warrants, cash proceeds were $95,714. The exercise of these warrants resulted in a reclassification of the derivative liability associated with these warrants of $5,022,351, which has been reclassified to from derivative liability to stockholders’ equity. Conversion of Convertible Note into Shares of Common Stock During the year ended December 31, 2017 the Company issued 667 shares of common stock for conversion of $57,000 of senior convertible debentures. The conversion of the $57,000 resulted in the reclassification of the derivative liability to equity for the embedded conversion feature of $30,717. During the year ended December 31, 2016 the Company issued 1,333 shares of common stock for the settlement of $114,000 of senior convertible debentures. Preferred Stock Series A Preferred Stock As of December 31, 2017, and 2016, the Company has designated 1,000,000 shares of Series A Preferred Stock par value $0.001 and 1,000,000 shares are issued and outstanding. The Series A Preferred Stock does not have any conversion provision or provides for cumulative dividends and each share of Series A Preferred Stock has voting rights equal to 667 shares of common stock. The Series A Preferred Stock has no redemption provision at the option of the holder and accordingly has been classified as permanent equity. Series B Convertible Preferred Stock On May 9, 2017 the Company filed a Certificate of Designation to designate 2,700 shares of Series B Convertible Preferred Stock. The Preferred Stock is convertible in shares of Common Stock at a price of $45.00 per share subject to subsequent equity sales reset provisions. The conversion provision was at the option of the holder and the Series B Convertible Preferred Stock did not provide for cumulative dividends and did not have any voting rights. The holders of Series B Convertible Preferred Stock would receive upon liquidation, the same amount that a holder of common stock would receive if the preferred stock were fully converted, paid pari passu with all holders of common stock. On May 9, 2017, the Company entered into an exchange agreement with an institutional investor. Under the terms of the agreement, the investor agreed to exchange with the Company, warrants exercisable for 1,479,904 shares of common stock, for (i) 2,700 shares of Series B Convertible Preferred Stock at a stated value of $1,000 per share and convertible into 60,000 shares of common stock at a conversion price of $45.00 and (ii) 66,667 shares of common stock. The Company cancelled 1,479,904 of warrants with a fair value of $4,666,773 on the date of the exchange, extinguished the derivative liability associated with the conversion feature in the amount of $350,922, and issued 2,700 shares of Series B Convertible Preferred Stock and 6,667 shares of common stock with an aggregate fair value of $5,652,500 The exchange resulted in an incremental increase of $513,725 which the Company has recorded as a loss on extinguishment of debt in other income (expense) in the statement of operations for the year ended December 31, 2017. During the year ended December 31, 2017, 2,700 shares of the Series B Convertible Preferred Stock were converted into 60,000 shares of the Company’s common stock an exchange rate of $45.00 per share. Series C Convertible Preferred Stock On June 15, 2017 the Company filed a Certificate of Designation to designate 25,000 shares of Series C Convertible Preferred Stock. The Preferred Shares have a stated value of $1,000 and each share of preferred stock is convertible into common stock at a conversion price of $45.00 per share. The holders of Preferred Shares are entitled to receive dividends, when and as declared by the Board and after the occurrence of a triggering event. Until such time as all triggering events then outstanding are cured, the holders shall be entitled to receive dividends at a rate of eighteen percent (18.0%) per annum, At any time the holder may, at its option, convert any Preferred Shares at an alternate conversion price as follows: The lower of (A) the applicable conversion price as then in effect and (B) the greater of (x) $5.25 and (y) the lowest of (i) 85% of the Value Weighted Average Price (“VWAP”) of the common stock as of the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, (ii) 85% of the VWAP of the common stock as of the trading day of the delivery or deemed delivery of the applicable conversion notice and (iii) 85% of the price computed as the quotient of (I) the sum of the VWAP of the common stock for each of the ten (10) trading days with the lowest VWAP of the common stock during the twenty (20) consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, divided by (II) ten (10). In lieu of conversion, upon a triggering event, the holder may require the Company to redeem all or any of the Preferred Shares at a price equal to the greater of (i) the product of (A) the conversion amount of the Preferred Shares to be redeemed multiplied by (B) a redemption premium of 115% and (ii) the product of (X) the conversion rate with respect to the conversion amount in effect at such time of redemption multiplied by (Y) the product of (1) a redemption premium of 115% multiplied by (2) the greatest closing sale price of the common stock on any trading day during the period commencing on the date immediately preceding such Triggering Event and ending on the date the Company makes the entire redemption payment. The Company may, at its option following notice to each holder, redeem such amount of Preferred Shares by paying to each holder the corresponding installment amount in cash. The applicable installment conversion price with respect to a particular date of determination, shall be equal to the lower of (A) the conversion price then in effect and (B) the greater of (x) $5.25 and (y) the lower of (i) 85% of the VWAP of the common stock as of the trading day immediately preceding the applicable Installment Date and (ii) 85% of the quotient of (A) the sum of the VWAP of the common stock for each of the ten (10) trading days with the lowest VWAP of the common stock during the twenty (20) consecutive trading day period ending and including the trading day immediately prior to the applicable Installment Date, divided by (B) ten (10). If the Company elects to effect an installment redemption in lieu of an installment conversion, in whole or in part, such Preferred Shares shall be redeemed by the Company in cash on the applicable Installment Date in an amount equal to 103% of the applicable installment redemption amount. As a result of such Triggering Event discussed above, the Series C Preferred Stock has redeemable features which are not in the Company’s control and therefore Management has classified the Series C Preferred Stock in temporary equity in accordance with ASC 480-10-S99-3A on the Consolidated Balance Sheet. On June 12, 2017, the Company entered into a Securities Purchase Agreement (“SPA”) with one or more investors. Under the terms of the agreement, the Company issued to each investor, Series C Convertible Preferred Stock, Series C Convertible Preferred Warrants and Warrants, for a total gross purchase price of up to $25,000,000. At the initial closing under the SPA, the Company issued a total of 75 Preferred Shares at a purchase price of $900 per share. The Preferred Warrants are exercisable for a total of 24,925 Preferred Shares at an exercise price of $900 per share. The Preferred Shares have an initial conversion price of $45.00 and are initially convertible into an aggregate of 8,555,556 shares of common stock. The Common Stock Warrants are exercisable for 194,444 shares of common stock, representing thirty-five percent (35%) of the total number of shares of common stock initially issuable upon conversion of the Preferred Shares. The exercise price of the Common Stock Warrants is $45.00 per share and are exercisable for 5 years. During the year ended December 31, 2017, the warrant holders exercised 3,528 Preferred Warrants into 3,528 Preferred Shares. The investors simultaneously converted 3,413 shares (and the previously issued 75 Preferred Shares) which had a stated value of $3,413,000 into 634,482 shares of the Company’s Common Stock. Management analyzed the conversion features of the Series C Preferred stock underlying the Preferred Warrants and recorded a beneficial conversion feature in the amount of $3,528,000. The beneficial conversion feature was recognized as a deemed dividend. In addition because the Preferred Warrants may not be exercised into preferred shares unless the registration statement is effective, no derivative liability has been recognized. As of December 31, 2017 the Company had 115 Series C shares outstanding with a stated value of $115,000. Series D Convertible Preferred Stock On July 21, 2017, the Company designated preferred stock as Series D Convertible Preferred Stock. The authorized number of Series D Convertible Preferred Stock was 694,222 each preferred share shall have a par value of $0.001. The holders are entitled to receive dividends, when and as declared by the Board. The Preferred Shares have a stated value of $15.00 per share. The initial conversion price of the preferred shares to common stock will be $15.00. In addition, under the Series D Convertible Preferred Stock designation holders representing at 65% of the aggregate stated value amount of the Preferred Shares then outstanding shall be required for any change, waiver or amendment to the certificate of designations provided, that 65% must include the holders as long as they beneficially owns any preferred shares. Upon the occurrence of a triggering event as disclosed in the Series E Convertible Preferred Stock designation until such time as all triggering events then outstanding are cured, the holders shall be entitled to receive dividends at a rate of 18.0% per annum. At any time the holder may, at its option, convert the Series D Convertible Preferred Stock under an alternate conversion price which is the lower of the applicable conversion price in effect on the applicable conversion date of the applicable alternate conversion and the greater of the following: a) the floor price and the lowest of 75% of the closing bid price of the common Stock as of the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, b) 75% of the variable weighted average price of the common stock as defined in the preferred designation In lieu of conversion, upon a triggering event, the holder may require the Company to redeem all or any of the preferred shares at a price equal to the greater of calculations as defined in the preferred designation; accordingly, the Company has classified the Series E Convertible Preferred Stock as temporary equity On July 21, 2017, the Company entered into a SPA with one or more investors. Under the terms of the agreement, the Company issued in the aggregate 10,000 shares of common stock and Series D Convertible Preferred Warrants for a total gross purchase price of $826,182. The preferred warrants have a life of 2.43 years and have an exercise price of $1.00. On July 27, 2017, at the initial closing under the SPA, the Company issued to the Investors a total of 10,000 shares of Common Stock at a purchase price of $13.17 per share. The Preferred Warrants are exercisable for a total of 694,422 Preferred Shares at an exercise price of $1.00 per share. The Preferred Shares have an initial conversion price of $15.00 and are initially convertible into an aggregate of 46,295 shares of Common Stock. Management analyzed the conversion features of the Series D Preferred stock underlying the Preferred Warrants and recorded a beneficial conversion feature in the amount of $826,182. The beneficial conversion feature was recognized as a deemed dividend. In addition because the Preferred Warrants may not be exercised into preferred shares unless the registration statement is effective, no derivative liability has been recognized. During the year ended December 31, 2017, the 694,422 shares of Series D Preferred Shares were converted into 120,100 shares of the Company’s Common Stock at an average conversion price of $5.85 per share. Series D-1 Convertible Preferred Stock As of December 31, 2016, the Company has designated 1,060 shares of Series D-1 Convertible Preferred Stock par value $0.001 of which none are outstanding. The Series D-1 Convertible Preferred Stock included a conversion feature where by the holder could convert its Series D-1 Convertible Preferred Stock into common stock at a price of $1,500 per share and the conversion price was subject to subsequent equity sale reset provisions. The conversion provision was at the option of the holder and the Series D-1 Convertible Preferred Stock did not provide for cumulative dividends and carries no redemption provision outside the control of the Company. The designation of shares as Series D-1 Convertible Preferred Stock was extinguished with the Company’s filing on June 14, 2017, of an amendment to the Certificate of Incorporation. Series D-2 Convertible Preferred Stock As of December 31, 2016, the Company has designated 940 shares of Series D-2 Convertible Preferred Stock of which none are outstanding. The Series D-2 Convertible Preferred Stock included a conversion into common stock at a price of $1,500 per share and the conversion price par value $0.001 was subject to subsequent equity sale reset provisions. The conversion provision was at the option of the holder and the Series D-2 Convertible Preferred Stock did not provide for cumulative dividends and carries no redemption provision outside the control of the Company. The designation of shares as Series D-2 Convertible Preferred Stock was extinguished with the Company’s filing on June 14, 2017, of an amendment to the Certificate of Incorporation. Series E Convertible Preferred Stock On September 15, 2017, the Company designated a new class of preferred stock as Series E Convertible Preferred Stock. The authorized number of Series E Convertible Preferred Stock was 455,882 each preferred share shall have a par value of $0.001. The holders are entitled to receive dividends, when and as declared by the Board. The Preferred Shares have a stated value of $1.36 per share. The initial conversion price of the preferred shares to common stock will be $1.36. In addition, under the Series E Convertible Preferred Stock designation holders representing at 65% of the aggregate stated value amount of the Preferred Shares then outstanding shall be required for any change, waiver or amendment to the certificate of designations provided, that 65% must include the holders as long as they beneficially owns any preferred shares. Upon the occurrence of a triggering event as disclosed in the Series E Convertible Preferred Stock designation until such time as all triggering events then outstanding are cured, the holders shall be entitled to receive dividends at a rate of 18.0% per annum. At any time the holder may, at its option, convert the Series E Convertible Preferred Stock under an alternate conversion price which is the lower of the applicable conversion price in effect on the applicable conversion date of the applicable alternate conversion and the greater of the following: a) the floor price and the lowest of 75% of the closing bid price of the common Stock as of the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, b) 75% of the variable weighted average price of the common stock as defined in the preferred designation In lieu of conversion, upon a triggering event, the holder may require the Company to redeem all or any of the preferred shares at a price equal to the greater of calculations as defined in the preferred designation Accordingly the Company has classified the Series E Convertible Preferred Stock as temporary equity During the year ended December 31, 2017 the Company issued 36,765 shares of Series E Convertible Preferred Stock and issued 419,117 Series E Preferred Convertible Preferred Stock Warrants as part of a security purchase agreement for consideration of $50,00 which was for stock issuance cost. The Series E Convertible Preferred Stock Warrants have a life of 2.28 years and an exercise price of $1.36. The Company recorded a beneficial conversion feature in the amount of $620,000 for the underlying preferred shares of the preferred warrant. The beneficial conversion feature was recognized as a deemed dividend. During the year ended December 31, 2017, the warrant holders exercised 419,117 Preferred Warrants into 419,117 Preferred Shares for a total gross purchase price of $569,999. The investors simultaneously converted 139,007 shares of Preferred Series E which had a stated value of $189,049 into 36,011 shares of common stock. As of December 31, 2017, the Company had 316,875 Series E shares Convertible Preferred Stock outstanding with a stated value of $430,950. Options Options outstanding as of December 31, 2017 and 2016 consisted of the following: Weighted Weighted Average Average Options Exercise Remaining Intrinsic Outstanding Price Life in Years Value December 31, 2015 28,473 198.00 2.4 968,000 Granted 4,035 93.00 5.0 - Exercised — Forfeited — Expired — December 31, 2016 32,508 93.54 1.23 13.60 Granted — Exercised — Forfeited — Expired (17,166 ) 34.73 December 31, 2017 15,342 159.34 1.58 0 Exercisable at December 31, 2017 15,342 As of December 31, 2017, the fair value of non-vested options totaled $446,183 which will be amortized to expense over the weighted average remaining term of 1.58 years. The fair value of each employee option grant is estimated on the date of the grant using the Black-Scholes option-pricing model. Key weighted-average assumptions used to apply this pricing model during the year ended 2016 were as follows: Risk free interest rate 1.10 % Expected term 3-5 years Volatility 55.6 % Dividends $ 0 On July 12, 2017, the Board of Directors submitted the following actions to the Majority Stockholder for ratification and approval by consent in lieu of meeting, and the Majority Stockholder has ratified and approved the following actions: approving the MagneGas Corporation Amended and Restated 2014 Equity Incentive Award Plan (the “New Plan”), for the principal purpose of increasing the number of shares that may be issued or transferred pursuant to awards under the New Plan. As of December 31, 2017, there are 15,432 shares to be issued upon exercise of outstanding options, warrants and rights and 784.3 shares remaining available for future issuance under equity compensation plans. Common Stock Warrants Warrants outstanding as of December 31, 2017 and 2016 consisted of the following: Weighted Weighted Average Average Warrants Exercise Remaining Outstanding Price Life in Years Balance -December 31, 2015 51,352 199.50 Granted 186,061 82.50 Exercised (63,810 ) 1.50 Forfeited/Exchanged - - Expired (20,321 ) Balance -December 31, 2016 153,282 136.50 5.8 Granted 22,222 455.63 5.0 Exercised (5,291 ) 15.00 Expired (147,991 ) 136.50 Balance- December 31, 2017 22,222 455.63 4.45 Exercisable at December 31, 2017 22,222 During the year ended December 31, 2017 the Company issued 5,291 shares of common stock for the exercise of warrants, cash proceeds were $7,937. At December 31, 2017 and 2016, the total intrinsic value of warrants outstanding and exercisable was $0 and $0, respectively. Maxim Group, LLC (“Maxim”) acted as the exclusive placement agent for the Series C preferred stock transaction. The Company agreed to pay Maxim a cash fee payable upon each closing equal to 6.0% of the gross proceeds ($4,050 in cash fees and a legal expense reimbursement of $5,000) received by the Company at each Closing (the “Placement Fee”). Such fees were recognized as stock issuance costs. Additionally, the Company granted to Maxim (or its designated affiliates) warrants to purchase up to 416,667 shares common stock (the “Placement Agent Warrants”). The Placement Agent Warrants expire five (5) years after the Closing. The Placement Agent Warrants are exercisable at a price per share equal to $49.50, are not be redeemable and are exercisable for 5 years. The Placement Agent Warrants may be exercised in whole or in part and provide for a “cashless” exercise, except in the event the shares of common stock issuable upon exercise of the Placement Agent Warrants are registered for resale, in which case they provide for a “cash” exercise only. The Placement Agent Warrants were recorded at fair value as a stock issuance costs. Although the Placement Agent Warrants contain certain change in control provisions that are potentially settleable in cash, such settlement is at the Company’s discretion. Preferred Stock Warrants Warrants outstanding to purchase Series C Preferred Stock as of December 31, 2017 consisted of the following: Weighted Weighted Average Average Warrants Exercise Remaining Outstanding Price Life in Years Balance -December 31, 2016 - - - Granted 24,925 900 5.0 Exercised (3,528 ) 900 Forfeited/Exchanged - - Expired Balance- December 31, 2017 21,397 900 4.45 Exercisable at December 31, 2017 21,397 At December 31, 2017 and 2016, the total intrinsic value of preferred stock warrants outstanding and exercisable was $0 and $0, respectively.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 12 - RELATED PARTY TRANSACTIONS The Company previously occupied 5,000 square feet of a building owned by a related party. Rent was payable at $4,000 on a month to month basis. The facility allowed for expansion needs. The lease was held by EcoPlus, Inc., a company that is effectively controlled by Dr. Ruggero Santilli, a former officer and director of the Company and one of the people who currently has voting and investment control over 1,000,000 shares of Series A Preferred Stock which, in turn, has 100,000 votes per share on any matters brought to a vote of the common stock shareholders. Rent expense for both the year ended December 31, 2017 and 2016 under this lease was approximately $12,000 and $48,000, respectively. The lease was terminated on May 27, 2017.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 13 - COMMITMENTS AND CONTINGENCIES Litigation Certain conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable, but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed. There can be no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. On April 16, 2015, there was an accident at the Company’s facilities which occurred during the gas filling process. As a result of the accident, one employee was killed and one was injured but has recovered and has returned to work. Although the Company has Workers Compensation Insurance and General Liability Insurance, the financial impact of the accident is unknown at this time. No customers have terminated their relationship with the Company as a result of the accident. On October 14, 2015 the Company received a final report from the Occupational and Safety Hazard Administration (“OSHA”) related to the accident. The OSHA report included findings, many of which were already resolved and a proposed citation. The Company was not cited for any willful misconduct and no final determination was made as to the cause of the accident. The Company received citations related to various operational issues and received a fine of $52,000. The Company has also been informed by the U.S. Department of Transportation that it has closed its investigation with no findings or citations to the Company. The U.S. Department of Transportation has the right to re-open the investigation should new information become available. On November 18, 2016 a lawsuit was filed in District Court in Pinellas County, Florida by the Estate of Michael Sheppard seeking unspecified damages. The lawsuit alleges that the Company was negligent and grossly negligent in various aspects of its safety, training and overall work environment that led to the accident. The Company was not cited by OSHA for any willful misconduct nor did it receive any citations from the Department of Transportation. As of December 31, 2017, the Company has not accrued for any contingency. The Company responded to this lawsuit in 2016 and as of the date of this filing, has not heard back from the plaintiff.

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Tax	NOTE 14 - INCOME TAX On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Reform Bill”) was signed into law. Prior to the enactment of the Tax Reform Bill, the Company measured its deferred tax assets at the federal rate of 34%. The Tax Reform Bill reduced the federal tax rate to 21% resulting in the re-measurement of the deferred tax asset as of December 31, 2017. Beginning January 1, 2018, the lower tax rate of 21% will be used to calculate the amount of any federal income tax due on taxable income earned during 2018. Income tax expense (benefit) consist of the following for the years ended December 31, consist of the following: U.S. federal 2017 2016 Current: — — Deferred 3,160,000 (3,900,000 ) State and local Current — — Deferred (1,000,000 ) (400,000 ) Total (2,160,000 ) (4,300,000 ) Change in valuation allowance 4,890,000 4,300,000 Income Tax Provision - - The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective rate for the years ended December 31, 2017 and 2016 is as follows: 2017 2016 U.S. federal statutory rate 34.00 % 34.00 % State income taxes, net of federal benefit 4.22 % 2.41 % Other permanent items 4.71 % -10.41 % Effect of federal tax rate change (66.96 )% -1.46 % Effect of state tax rate change 3.76 % - Change in valuation allowance 20.27 % -24.55 % Effective rate 0.00 % 0.00 % As of December 31, 2017, and 2016, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following: Deferred tax assets 2017 2016 Net Operating Loss carryover $ 14,400,000 $ 16,000,000 Stock-based compensation 600,000 900,000 Other - 600,000 Total deferred tax asset 15,000,000 17,300,000 Less reserve for allowance 15,000,000 17,300,000 Total Deferred tax asset net of valuation allowance $ - $ - The tax loss carry-forwards of the Company may be subject to limitation by Section 382 of the Internal Revenue Code with respect to the amount utilizable each year. This limitation reduces the Company’s ability to utilize net operating loss carry-forwards. The Company has not completed a detailed Section 382 study at this time to determine what impact, if any, that ownership changes may have had on its NOL carry forwards. On December 22, 2017, new legislation was signed into law, informally titled the Tax Cuts and Jobs Act, which included, among other things, a provision to reduce the federal corporate income tax rate to 21%. Under ASC 740, Accounting for Income Taxes, the enactment of the Tax Act also requires companies, to recognize the effects of changes in tax laws and rates on deferred tax assets and liabilities and the retroactive effects of changes in tax laws in the period in which the new legislation is enacted. There is no further change to its assertion on maintaining a full valuation allowance against its U.S. deferred tax assets. The Company’s gross deferred tax assets have been revalued from 35% to 21% with a corresponding offset to the valuation allowance and any potential other taxes arising due to the Tax Act will result in reductions to its net operating loss carryforward and valuation allowance. Deferred tax assets of approximately $24.7 million have been revalued to approximately $15.0 million with a corresponding decrease to the Company’s valuation allowance. Upon completion of our 2017 U.S. income tax return in 2018 we may identify additional remeasurement adjustments to our recorded deferred tax liabilities. We will continue to assess our provision for income taxes as future guidance is issued, but do not currently anticipate significant revisions will be necessary. Any such revisions will be treated in accordance with the measurement period guidance outlined in Staff Accounting Bulletin No. 118. The Company files income tax returns in the U.S. federal and various state jurisdictions. As of December 31, 2017 and 2016, the Company has federal and state net operating loss carryforwards each of $54,536,000 and $42,374,000, respectively. As of December 31, 2017, the tax returns for the years from 2014 through 2017 remain open to examination by the Internal Revenue Service and various state authorities. ASC 740, “Income Taxes” requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be recognized. A review of all available positive and negative evidence needs to be considered, including the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. After consideration of all the information available, management believes that uncertainty exists with respect to future realization of its deferred tax assets and has, therefore, established a full valuation allowance as of December 31, 2017 and 2016. For the year ended December 31, 2017 the change in valuation allowance was $590,000. As of December 31, 2017, and 2016, the Company has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s financial statements. The Company’s policy is to classify assessments, if any, for tax related interest as income tax expenses. No interest or penalties were recorded during the years ended December 31, 2017 and 2016. The Company does not expect its unrecognized tax benefit position to change during the next twelve months.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
Subsequent Events	NOTE 15 – SUBSEQUENT EVENTS Related Party Debt: During the period January 1, 2018 through April 2, 2018, $67,458 in related party debt was repaid. Equity: During the period January 1, 2018 through April 11, 2018, the warrant holders exercised 9,991 Preferred Warrants into 9,991 Series C Preferred Shares. The investors converted 9,550 Series C Preferred Shares into 9,150,370 shares of the Company’s Common Stock. During the period January 1, 2018 through April 11,2018, the warrant holders exercised 0 Preferred Warrants into 0 Series E Preferred Shares. The investors converted 280,111 Series E Preferred Shares into 135,754 shares of the Company’s Common Stock. Employment Agreements: On March 13, 2018, the Company entered into a new employment agreement with Ermanno Santilli (“Santilli Employment Agreement”). Pursuant to the terms of the agreement Mr. Santilli will continue to serve as the Company’s chief executive officer and will receive an annual salary of $235,000 per year. The agreement includes the grant of 100,000 time-vested common stock options with strike price set at the Company’s closing share price on March 13, 2018. 50,000 common stock options vested on March 13, 2018 and the remaining 50,000 common stock options will vest 1/24 th th On March 13, 2018, the Company entered into a new employment agreement with Scott Mahoney (“Mahoney Employment Agreement”). Pursuant to the terms of the agreement Mr. Mahoney will continue to serve as the Company’s chief financial officer and will receive an annual salary of $215,000 per year. The agreement includes the grant of 100,000 time-vested common stock options with strike price set at the Company’s closing share price on March 13, 2018. 50,000 common stock options vested on March 13, 2018 and the remaining 50,000 common stock options will vest 1/24 th th Asset Purchase Agreements: On January 19, 2018, the Company entered into an Amended and Restated Asset Purchase Agreement (“Amended Asset Purchase Agreement”) with GGNG Enterprises Inc. (formerly known as NG Enterprises, Inc.) and Guillermo Gallardo (collectively, the “Seller”) and closed the purchase of certain assets related to the Seller’s welding supply and gas distribution business in San Diego, California. The Amended Asset Purchase Agreement amended certain material terms of that certain Asset Purchase Agreement entered into between the Company and the Seller on December 29, 2017. The primary purpose of the Amended Asset Purchase Agreement was to expand the assets being purchased to include certain gas cylinders having an approximate value of $350,000 and simultaneously reducing the value of the account receivables being acquired. Under the terms of the Amended Asset Purchase Agreement, the Company purchased from the Seller all of the Seller’s right, title an interest to the Purchased Assets (as defined in the Asset Purchase Agreement). The total purchase price for the Purchased Assets was $745,000. In conjunction with the Amended Asset Purchase Agreement, the Company and the Seller entered into an Assignment and Bill of Sale and Assumption Agreement (“Bill of Sale”) on January 19, 2018. Upon consummation of the closing, on January 19, 2018, the Company commenced business operations in San Diego, California through its wholly owned subsidiary NG Enterprises Acquisition, LLC and is doing business as “Complete Welding San Diego”. On February 16, 2018, the Company entered into an Asset Purchase Agreement (“Asset Purchase Agreement”) with Green Arc Supply, L.L.C. (the “Seller”) and closed the purchase of certain assets related to the Seller’s welding supply and gas distribution business located in Louisiana and Texas. Under the terms of the Asset Purchase Agreement, the Company purchased from the Seller all of the Seller’s right, title an interest to the Purchased Assets and the Assumed Liabilities (as defined in the Asset Purchase Agreement. The total purchase price for the Purchased Assets and Assumed Liabilities was $2,500,000, which was comprised of a $1,000,000 cash payment and the issuance of that number of shares of restricted common stock equal to $1,500,000 divided by the ten-day VWAP as of the closing date. The Asset Purchase Agreement also includes certain conditional and bonus payments to the Seller, subject to certain performance criteria being met, as well as other terms and conditions which are typical in asset purchase agreements. In conjunction with the Asset Purchase Agreement, the Company and the Seller entered into an Assignment and Bill of Sale and Assumption Agreement (“Bill of Sale”) on February 16, 2018. The Bill of Sale conveyed the Purchased Assets and Assumed Liabilities (as defined in the Asset Purchase Agreement) to the Company. Further, in conjunction with the Asset Purchase Agreement, the Company entered into four (4) Assignment, Assumption and Amendment to Lease Agreements (each a “Lease Assumption Agreement”) with the Seller and the landlords of certain real property leased by the Seller for the operation of the Seller’s business locations in Louisiana and Texas. Securities Purchase Agreement: On April 3, 2018, the Company entered into a Securities Purchase Agreement (“SPA”) with Robert Baker, Joseph Knieriem (collectively, the “Sellers”) and Trico Welding Supplies, Inc., a California corporation (“Trico”) for the purchase of all of the issued and outstanding capital stock of Trico by the Company. Under the terms of the SPA, the Company purchased one hundred percent (100%) of Trico’s issued and outstanding capital stock for the gross purchase price of $2,000,000 (“Trico Stock”). The SPA includes certain other terms and conditions which are typical in securities purchase agreements. On March 21, 2018, the Company made an initial non-refundable deposit for the purchase of the Trico Stock. Upon execution of the SPA the Company funded the remaining $1,000,000 balance due. Effective at closing, the Company commenced business operations in northern California through its new wholly owned subsidiary Trico Welding Supplies, Inc.

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The Company prepares its financial statements in conformity with U.S. GAAP. These principles require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management believes that these estimates are reasonable and have been discussed with the Board of Directors; however, actual results could differ from those estimates. The consolidated financial statements presented include inventory reserves, fair value of derivative financial instruments, recoverability of deferred tax assets and collections of its receivables.
Concentrations of Credit Risk	Concentrations of Credit Risk The Company maintains its cash accounts at financial institutions which are insured by the Federal Deposit Insurance Corporation (“FDIC”). At times, the Company may have deposits in excess of federally insured limits.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash, checking accounts, money market accounts and temporary investments with original maturities of three months or less when purchased. As of December 31, 2017, and 2016 the Company had no cash equivalents.
Accounts Receivable	Accounts Receivable Accounts receivable consist of amounts due for the delivery of MagneGas2® sales to customers with payment terms of generally 30 days. An allowance for doubtful accounts is established for any amounts that may not be recoverable, which is based on an analysis of the Company’s customer credit worthiness, historical estimates, and current economic trends. Receivables are determined to be past due, based on payment terms of original invoices. The Company does not typically charge interest on past due receivables. The allowance for doubtful accounts was $101,063 and $145,931 for the years ended December 31, 2017 and 2016, respectively.
Inventory	Inventory Inventory is stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. Inventory is comprised of spare parts; consumables used in the production of gas, regulators and tips and work in process. Estimates of lower of cost or net realizable value are based upon economic conditions, historical sales quantities and patterns, and in some cases, the specific risk of loss on specifically identified inventories. The Company evaluates inventories on a regular basis to identify inventory on hand that may be slow moving. Inventory that is in excess of current and projected use is reduced by an allowance to the level that approximates its estimate of future demand. In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory (“ASU 2015-11”). ASU 201-11 requires that inventory measured using any method other than last-in, first out (“LIFO”) or the retail inventory method to be subsequently measured at the lower of cost or net realizable value, rather than at the lower of cost or market value. Under this ASU, subsequent measurement of inventory using the LIFO and retail inventory method is unchanged. ASU 2015-11 is effective prospectively for fiscal years, and for interim periods within those years, beginning after December 15, 2016. We adopted this standard effective January 1, 2017. The adoption of this standard did not have a material impact on our consolidated financial statements.
Property and Equipment, Net	Property and equipment, net Property and equipment are stated at cost net of accumulated depreciation using the straight–line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which range from three to thirty-nine and a half years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures which extend the economic life are capitalized. When assets are retired, or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized.
Intangible Assets, Net	Intangible assets, net The Company’s recorded intangible assets consist of intellectual property. Applicable long–lived assets are amortized or depreciated over the shorter of their estimated useful lives, the estimated period that the assets will generate revenue, or the statutory or contractual term. Estimates of useful lives and periods of expected revenue generation are reviewed periodically for appropriateness and are based upon management’s judgment. Intangible assets are amortized on the straight-line method over their useful lives of 15 years.
Goodwill and Other Indefinite-lived Assets	Goodwill and Other Indefinite-lived Assets The Company records goodwill and other indefinite-lived assets in connection with business combinations. Goodwill, which represents the excess of acquisition cost over the fair value of the net tangible and intangible assets of acquired companies, is not amortized. Indefinite-lived assets are stated at fair value as of the date acquired in a business combination. The Company assesses the recoverability of goodwill and certain indefinite-lived intangible assets annually in the fourth quarter and between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. Impairment testing for goodwill is done at a reporting unit level. Under Financial Accounting Standards Board (“FASB”) guidance for goodwill and intangible assets, a reporting unit is defined as an operating segment or one level below the operating segment, called a component. However, two or more components of an operating segment will be aggregated and deemed a single reporting unit if the components have similar economic characteristics. The Company operates as one reporting unit. Authoritative accounting guidance allows the Company to first assess qualitative factors to determine whether it is necessary to perform the more detailed two-step quantitative goodwill impairment test. The Company performs the quantitative test if its qualitative assessment determined it is more likely than not that a reporting unit’s fair value is less than its carrying amount. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test for any reporting unit or asset. The quantitative goodwill impairment test, if necessary, is a two-step process. The first step is to identify the existence of a potential impairment by comparing the fair value of a reporting unit (the estimated fair value of a reporting unit is calculated using a discounted cash flow model) with its carrying amount, including goodwill. If the fair value of a reporting unit exceeds its carrying amount, the reporting unit’s goodwill is considered not to be impaired and performance of the second step of the quantitative goodwill impairment test is unnecessary. However, if the carrying amount of a reporting unit exceeds its fair value, the second step of the quantitative goodwill impairment test is performed to measure the amount of impairment loss to be recorded, if any. The second step of the quantitative goodwill impairment test compares the implied fair value of the reporting unit’s goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit’s goodwill exceeds its implied fair value, an impairment loss is recognized in an amount equal to that excess. The implied fair value of goodwill is determined using the same approach as employed when determining the amount of goodwill that would be recognized in a business combination. That is, the fair value of the reporting unit is allocated to all of its assets and liabilities as if the reporting unit had been acquired in a business combination and the fair value was the purchase price paid to acquire the reporting unit. For the 2017 annual goodwill and certain indefinite-lived intangible assets impairment tests, the Company elected to bypass the qualitative assessment and proceeded directly to the quantitative analysis using the market price of the stock and determined that no impairment was deemed to exist as of December 31, 2017.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets The Company assesses the recoverability of its long-lived assets, including property and equipment, when there are indications that the assets might be impaired. When evaluating assets for potential impairment, the Company compares the carrying value of the asset to its estimated undiscounted future cash flows. If an asset’s carrying value exceeds such estimated undiscounted cash flows, the Company records an impairment charge for the difference between the carrying amount of the asset and its fair value. Based on its assessments, the Company did not record any impairment charges for the year ended December 31, 2017 and recorded an impairment charge of $806,716 for the year ended December 31, 2016.
Revenue Recognition	Revenue Recognition The Company generates revenue through three processes: (1) the sale of its MagneGas2® fuel for metal cutting and (2) the sale of its Plasma Arc Flow Units. Additionally, and (3) the Company also recognizes revenue from territorial license arrangements, and through the sales of metal cutting gases and related products through their wholly owned subsidiary, ESSI. ● Revenue for metal-working fuel and related products are recognized when shipments are made to customers. The Company recognizes a sale when the fuel and/or product has been shipped and risk of loss has passed to the customer and collectability is reasonably assured. Cylinder rentals are billed on a monthly basis. ● Revenue generated from sales of each Plasma Arc Flow Unit is recognized upon delivery. Significant deposits are required before production commences. These deposits are classified as customer deposits. ● Licenses are issued, per contractual agreement, for distribution rights within certain geographic territories. The Company recognizes revenue ratably, based on the amounts paid or values received, over the term of the licensing agreement. The Company, on occasion, may recognize revenue under a bill-and-hold arrangement. Under a bill-and-hold arrangement revenue is recognized when the product is manufactured, completed, invoiced and segregated from the seller’s other inventory so that it is not subjected to being used to fill other orders. Upon invoicing under this arrangement, ownership has passed to the buyer with no right of return such that the earnings process is complete. The customer must request a bill-and-hold arrangement (preferably in writing), must commit to the purchase and the delivery date must be fixed. During the year ended December 31, 2016, the Company recognized $775,000 of revenues under this arrangement. The Company also enters into sales transactions whereby customer orders contain multiple deliverables and reports its multiple deliverable arrangements under ASC 605-25 “Revenue Arrangements with Multiple Deliverables” (“ASC-605-25”). These multiple deliverable arrangements primarily consist of the following deliverables: the Company’s MagneGas units, design, configuration, installation and training services. In situations where the Company bundles all or a portion of the separate elements, Vendor Specific Objective Evidence (“VSOE”) is determined based on prices when sold separately. For the years ended December 31, 2017 and 2016, multiple deliverable arrangements were immaterial.
Preferred Stock	Preferred Stock The Company applies the accounting standards for distinguishing liabilities from equity under U.S. GAAP when determining the classification and measurement of its Preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred shares are classified as permanent equity.
Derivative Liability	Derivative Liability The Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with Accounting Standards Codification 815-10-05-4 and 815-40-25. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date. The Company had no derivative liabilities as of December 31, 2017 and derivative liabilities of $7,700,585 at December 31, 2016.
Beneficial Conversion Feature of Convertible Notes Payable	Beneficial conversion feature of convertible notes payable The Company accounts for convertible notes payable in accordance with the guidelines established by the FASB Accounting Standards Update (“ASU”) Topic 470-20, Debt with Conversion and Other Options. The beneficial conversion feature of a convertible note is normally characterized as the convertible portion or feature of certain notes payable that provide a rate of conversion that is below market value or in-the-money when issued. The Company records a beneficial conversion feature related to the issuance of a convertible note when issued and also records the estimated fair value of any warrants issued with those convertible notes. The beneficial conversion features that are contingent upon the occurrence of a future event are recorded when the contingency is resolved. The effective conversion price and the market price of the Company’s common stock are used to calculate the intrinsic value of the conversion feature. The intrinsic value is recorded in the financial statements as a debt discount from the face amount of the note and such discount is amortized over the expected term of the convertible note (or to the conversion date of the note, if sooner) and is charged to interest expense.
Advertising Costs	Advertising Costs The costs of advertising are expensed as incurred. Advertising expenses are included in the Company’s operating expenses. Advertising expense was $4,218 and $110,755 for the years ended December 31, 2017 and 2016, respectively.
Research and Development	Research and Development The Company expenses research and development costs when incurred. Research and development costs include engineering and laboratory testing of product and outputs.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation costs under the provisions of Accounting Standards Codification 718, “Compensation—Stock Compensation” (“ASC 718”), which requires the measurement and recognition of compensation expense related to the fair value of stock-based compensation awards that are ultimately expected to vest. Stock based compensation expense recognized includes the compensation cost for all stock-based payments granted to employees, officers, and directors based on the grant date fair value estimated in accordance with the provisions of ASC 718. ASC 718 is also applied to awards modified, repurchased, or canceled during the periods reported. The Company incurred stock-based compensation charges, net of estimated forfeitures of $425,492 and $346,906 for the year ended December 31, 2017 and 2016, respectively and has included such amounts in selling, general and administrative expenses in the consolidated statements of operations.
Stock-Based Compensation for Non-Employees	Stock-Based Compensation for Non-Employees The Company accounts for warrants and options issued to non-employees under Accounting Standards Codification 505-50, “Equity – Equity Based Payments to Non-Employees”, using the Black-Scholes option-pricing model. The value of such non-employee awards unvested are re-measured over the vesting terms at each reporting date.
Warranty Liabilities	Warranty Liabilities The Company accrues an estimate of their exposure to warranty claims based on both current and historical product sales data and warranty costs incurred. The majority of the Company’s products carry a 1-year parts and labor warranty. Additional components carry a warranty from their own manufacturers. All such warranty details will be passed from Manufacturer to Buyer on or before delivery. The Company assesses the adequacy of their recorded warranty liability annually and adjusts the amount as necessary. As of December 31, 2017 and 2016, the accrued warranty liability was deemed to be immaterial.
Income Taxes	Income Taxes The Company accounts for income taxes under the liability method. Deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purpose, referred to as temporary differences. Deferred tax assets and liabilities at the end of each period are determined using the currently enacted tax rates applied to taxable income in the periods in which the deferred tax assets and liabilities are expected to be settled or realized. The Company is subject to examination by U.S. tax authorities beginning with December 31, 2014. On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Reform Bill”) was signed into law. Prior to the enactment of the Tax Reform Bill, the Company measured its deferred tax assets at the federal rate of 34%. The Tax Reform Bill reduced the federal tax rate to 21% resulting in the re-measurement of the deferred tax asset as of December 31, 2017. Beginning January 1, 2018, the lower tax rate of 21% will be used to calculate the amount of any federal income tax due on taxable income earned during 2018.
Basic and Diluted Net (Loss) per Common Share	Basic and Diluted Net (Loss) per Common Share Basic (loss) per common share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding for each period. Diluted (loss) per share is computed by dividing the net (loss) by the weighted average number of shares of common stock outstanding plus the dilutive effect of shares issuable through the common stock equivalents. As of December 31, 2017, and 2016 the Company’s common stock equivalents outstanding. December 31, 2017 2016 Options 15,340 31,530 Common Stock Warrants 222,222 155,108 Convertible preferred stock 147,901 - Convertible secured debentures - 11,696 Total common stock equivalents outstanding 385,463 198,334
Recent Accounting Standards	Recent Accounting Standards Revenue Related Recent Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2014-09, “Revenue from Contracts with Customers,” (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in ASC 605 — Revenue Recognition and most industry-specific guidance throughout the ASC. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application. To allow entities additional time to implement systems, gather data and resolve implementation questions, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, in August 2015, to defer the effective date of ASU No. 2014-09 for one year, which is fiscal years beginning after December 15, 2017. The Company is currently evaluating the impact of the adoption of ASU 2014-09 on its financial statements or disclosures. In addition, the FASB issued ASU 2016-08 in March 2016, to help provide interpretive clarifications on the new guidance in ASC Topic 606. The Company is currently evaluating the accounting, transition, and disclosure requirements of the standard to determine the impact, if any, on its financial statements. In March 2016, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers—Principal versus Agent Considerations.” This update provides clarifying guidance regarding the application of ASU No. 2014-09 — Revenue from Contracts with Customers when another party, along with the reporting entity, is involved in providing a good or a service to a customer. In these circumstances, an entity is required to determine whether the nature of its promise is to provide that good or service to the customer (that is, the entity is a principal) or to arrange for the good or service to be provided to the customer by the other party (that is, the entity is an agent). The amendments in the Update clarify the implementation guidance on principal versus agent considerations. The update is effective, along with ASU 2014-09, for annual and interim periods beginning after December 15, 2017. ASU 2016-08 is not expected to have a material impact on the financial statements or disclosures. On May 2016, the FASB issued ASU No. 2016-12, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2016-12”). ASU 2016-12 provides clarifying guidance in a few narrow areas and adds some practical expedients to the guidance. The effective date and transition requirements for this ASU are the same as the effective date and transition requirements for ASU 2014-09. The Company is evaluating the effect of ASU 2014-09, if any, on its financial statements. In September 2017, the FASB issued ASU No. 2017-13, “Revenue Recognition (Topic 605), Revenue from Contracts with Customers (Topic 606), Leases (Topic 840), and Leases (Topic 842): Amendments to SEC Paragraphs Pursuant to the Staff Announcement at the July 20, 2017 EITF Meeting and Rescission of Prior SEC Staff Announcements and Observer Comments” that enhances the guidance surrounding sale leaseback transactions, accounting for taxes on leveraged leases and leases with third party value. The related amendments to the Topics described above become effective on the same schedule as Topics 605, 606, 840 and 842. The Company qualifies as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of relief from certain reporting requirements and other burdens that are otherwise applicable generally to public companies. These provisions include an exemption from the adoption of new or revised financial accounting standards until they would apply to private companies. As such, the Company has delayed the adoption of Accounting Standards Codification (“ASC”) No. 606, Revenue from Contracts with Customers until January 1, 2019. Other Recent Accounting Pronouncements In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which addresses the diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows with respect to eight specific cash flow issues. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017. The amendments should be applied using a retrospective transition method to each period presented, if practical. Early adoption is permitted, including the interim period, and any adjustments should be reflected as of the beginning of the fiscal period. ASU 2016-15 is not expected to have a material impact on the financial statements or disclosures. In October 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory”, In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230)” In May 2017, the FASB issued ASU 2017-09, “ Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting,” In July 2017, the FASB issued ASU 2017-11, “Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception”. Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company has adopted the accounting guidance. The adoption of this ASU resulted in the Company reclassifying $427,568 representing the fair value of the derivative liability on the date of the exchange to stockholders’ equity.
Subsequent Events	Subsequent Events The Company evaluates events that have occurred after the balance sheet date but before the financial statements are issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements, except as disclosed in Note 15.

Summary of Significant Accoun23

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2017
Accounting Policies [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	As of December 31, 2017, and 2016 the Company’s common stock equivalents outstanding. December 31, 2017 2016 Options 15,340 31,530 Common Stock Warrants 222,222 155,108 Convertible preferred stock 147,901 - Convertible secured debentures - 11,696 Total common stock equivalents outstanding 385,463 198,334

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2017
Fair Value Disclosures [Abstract]
Schedule of Fair Value on Recurring and Nonrecurring Basis	The following tables provides a summary of financial instruments that are measured at fair value as of December 31, 2017 and December 31, 2016, respectively. December 31, 2017 Quoted Prices In Active Significant Markets for Other Significant Identical Observable Unobservable Liabilities Inputs Inputs Total (Level 1) (Level 2) (Level 3) Warrant liability $ — — — $ — Embedded conversion feature — — — — Derivative liability – December 31, 2017 $ — — — $ — December 31, 2016 Quoted Prices In Active Significant Markets for Other Significant Identical Observable Unobservable Liabilities Inputs Inputs Total (Level 1) (Level 2) (Level 3) Warrant liability $ 7,195,617 — — $ 7,195,617 Embedded conversion feature 504,968 — — 504,968 Derivative liability – December 31, 2016 $ 7,700,585 — — $ 7,700,585
Schedule of Fair Value on Recurring Basis Using Significant Unobservable Inputs (level 3)	The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended December 31, 2017 and 2016: Embedded Total Warrant Conversion Derivative Liability Feature Liabilities Balance – December 31, 2015 $ 1,241,841 $ - $ 1,241,841 Change in fair value (386,182 ) 15,556 (370,626 ) Warrants issued in connection with debt transactions 446,588 553,412 1,000,000 Loss on modification of warrants 2,622,080 Excess fair value of warrants issued over related debt 2,879,291 - 5,591,371 Reclassification of equity instruments to derivative liabilities due to tainting of warrants 5,396,350 - 5,396,350 Reclassification of derivative liabilities to equity from the exercise of warrants and issuance of shares for convertible debt (5,022,351 ) (64,000 ) 5,086,351 ) Balance – December 31, 2016 7,195,617 504,968 7,700,585 Change in fair value (2,131,990 ) (123,332 ) (2,255,322 ) Reclassification of derivative liabilities to equity (396,854 ) (30,714 ) (427,568 ) Derivative extinguishment (4,666,773 ) (350,922 ) (5,017,695 ) Balance – December 31, 2017 $ — $ — $ —
Schedule of Fair Value on Recurring and Nonrecurring Valuation Techniques	Assumptions utilized in the valuation of Level 3 liabilities are described as follows: For the year ended December 31, 2017 2016 Risk free interest rate 0.2%-1.94 % 0.2%-2.25 % Expected term 0.25 to 7.07 years 0.25 to 7.25 years Volatility 62% to 142 % 51 to 123 % Dividends $ 0 $ 0

Inventory, Net (Tables)

Inventory, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventory primarily consists of: December 31, 2017 December 31, 2016 Production materials consumables, spare parts, and accessories $ 738,950 $ 937,133 Work in process - 853,800 Total at cost 738,950 1,790,933 Slow moving inventory allowance - (175,000 ) Inventory, net $ 738,950 $ 1,615,933

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Estimated useful life December 31, 2017 December 31, 2016 Machinery and equipment 3 – 5 years $ 482,263 $ 400,106 Furniture and office equipment 5 – 7 years 182,305 179,206 Transportation 3 – 5 years 222,144 303,826 Production units 5 – 30 years 4,910,736 4,757,896 Building 39.5 years 2,237,257 2,236,841 Parts n/a 862,949 - 8,897,654 7,877,875 Accumulated depreciation and amortization (2,032,265 ) (1,474,944 ) $ 6,865,389 $ 6,402,931

Intangible Assets, Net (Tables)

Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	The Company’s intangible assets consisted of the following: Estimated useful life December 31, 2017 December 31, 2016 Intellectual property 15 years $ 869,502 $ 838,398 Less: Accumulated amortization (457,171 ) (401,277 ) Intangible assets, net $ 412,331 $ 437,121
Schedule of Future Amortization Expense	The following table outlines estimated future annual amortization expense for the next five years and thereafter: December 31, 2018 $ 58,014 2019 58,014 2020 58,014 2021 58,014 2022 58,014 Thereafter 122,261 Total $ 412,331

Investments in Joint Ventures (

Investments in Joint Ventures (Tables)	12 Months Ended
	Dec. 31, 2017
Equity Method Investments and Joint Ventures [Abstract]
Schedule of Investments in Joint Ventures	The Company’s investment in joint ventures consisted of the following: Magnegas Europe $ 23,750 Magnegas China 466,660 Future Energy PTY, LTD 229,840 Other 34,351 Balance -December 31, 2015 754,601 Additional investments during 2016 52,115 806,716 Less impairment (806,716 ) Balance- December 31, 2016 and 2017, respectively -

Capitalized Leases (Tables)

Capitalized Leases (Tables)	12 Months Ended
	Dec. 31, 2017
Leases [Abstract]
Schedule of Future Minimum Lease Payments for Capital Leases	At December 31, 2017, annual minimum future lease payments under this capital lease are as follows: For the year ending December 31, Amount 2018 27,460 2019 27,460 2020 24,791 2021 18,132 2022 5,064 Total minimum lease payments 102,907 Less amount representing interest 11,608 Present value of minimum lease payments 91,299 Less current portion of minimum lease 27,460 Long-term present value of minimum lease payment $ 63,839

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Warrants to Purchase Common Stock	In connection with the debenture the Company granted the following warrants to purchase common stock of the Company to the investor as follows: Common stock Exercise Expiration Warrants Price Date 23,392 $ 157.50 12/23/2023 11,696 $ 195.00 12/23/2023 46,784 $ 151.50 12/31/2016 23,392 $ 157.50 12/27/2023 11,696 $ 195.00 12/27/2023

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2017
Schedule of Options Outstanding	Options outstanding as of December 31, 2017 and 2016 consisted of the following: Weighted Weighted Average Average Options Exercise Remaining Intrinsic Outstanding Price Life in Years Value December 31, 2015 28,473 198.00 2.4 968,000 Granted 4,035 93.00 5.0 - Exercised — Forfeited — Expired — December 31, 2016 32,508 93.54 1.23 13.60 Granted — Exercised — Forfeited — Expired (17,166 ) 34.73 December 31, 2017 15,342 159.34 1.58 0 Exercisable at December 31, 2017 15,342
Schedule of Stock Options Valuation Assumptions	Key weighted-average assumptions used to apply this pricing model during the year ended 2016 were as follows: Risk free interest rate 1.10 % Expected term 3-5 years Volatility 55.6 % Dividends $ 0
Common Stock Warrant [Member]
Schedule of Warrants Outstanding	Warrants outstanding as of December 31, 2017 and 2016 consisted of the following: Weighted Weighted Average Average Warrants Exercise Remaining Outstanding Price Life in Years Balance -December 31, 2015 51,352 199.50 Granted 186,061 82.50 Exercised (63,810 ) 1.50 Forfeited/Exchanged - - Expired (20,321 ) Balance -December 31, 2016 153,282 136.50 5.8 Granted 22,222 455.63 5.0 Exercised (5,291 ) 15.00 Expired (147,991 ) 136.50 Balance- December 31, 2017 22,222 455.63 4.45 Exercisable at December 31, 2017 22,222
Preferred Stock Warrant [Member]
Schedule of Warrants Outstanding	Warrants outstanding to purchase Series C Preferred Stock as of December 31, 2017 consisted of the following: Weighted Weighted Average Average Warrants Exercise Remaining Outstanding Price Life in Years Balance -December 31, 2016 - - - Granted 24,925 900 5.0 Exercised (3,528 ) 900 Forfeited/Exchanged - - Expired Balance- December 31, 2017 21,397 900 4.45 Exercisable at December 31, 2017 21,397

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit)	Income tax expense (benefit) consist of the following for the years ended December 31, consist of the following: U.S. federal 2017 2016 Current: — — Deferred 3,160,000 (3,900,000 ) State and local Current — — Deferred (1,000,000 ) (400,000 ) Total (2,160,000 ) (4,300,000 ) Change in valuation allowance 4,890,000 4,300,000 Income Tax Provision - -
Schedule of Effective Income Tax Rate Reconciliation	The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective rate for the years ended December 31, 2017 and 2016 is as follows: 2017 2016 U.S. federal statutory rate 34.00 % 34.00 % State income taxes, net of federal benefit 4.22 % 2.41 % Other permanent items 4.71 % -10.41 % Effect of federal tax rate change (66.96 )% -1.46 % Effect of state tax rate change 3.76 % - Change in valuation allowance 20.27 % -24.55 % Effective rate 0.00 % 0.00 %
Schedule of Deferred Tax Assets and Liabilities	As of December 31, 2017, and 2016, the Company’s deferred tax assets (liabilities) consisted of the effects of temporary differences attributable to the following: Deferred tax assets 2017 2016 Net Operating Loss carryover $ 14,400,000 $ 16,000,000 Stock-based compensation 600,000 900,000 Other - 600,000 Total deferred tax asset 15,000,000 17,300,000 Less reserve for allowance 15,000,000 17,300,000 Total Deferred tax asset net of valuation allowance $ - $ -

Organization and Description 33

Organization and Description of Business (Details Narrative)	1 Months Ended
	Oct. 30, 2014USD ($)
Equipment Sales and Services, Inc [Member]
Payments to acquire business	$ 3,000,000

Going Concern and Managements34

Going Concern and Managements' Plan (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 586,824	$ 1,616,410	$ 5,319,869
Net loss	11,024,388	17,469,928
Cash in operation	4,787,876	8,639,816
Working capital deficit	1,336,050
Accumulated deficit	64,582,868	$ 53,558,480
Cash burn rate amount	$ 430,000

Summary of Significant Accoun35

Summary of Significant Accounting Policies (Details Narrative)	Dec. 22, 2017	Dec. 31, 2017USD ($)Segment	Dec. 31, 2016USD ($)
Allowance for doubtful accounts		$ 101,063	$ 145,931
Estimated useful lives of intangible assets		15 years
Number of reporting segment unit | Segment		1
Asset impairment charges			806,716
Revenues		775,000
Advertising expense		4,218	110,755
Derivative liabilities			7,700,585
Stock-based compensation		$ 425,492	$ 346,906
Deferred tax asset federal rate	34.00%	0.00%	0.00%
Reduced federal tax rate		21.00%
Fair value of derivative liability		$ 427,568
Minimum [Member]
Property and equipment estimated useful life		3 years
Maximum [Member]
Property and equipment estimated useful life		39 years 6 months

Summary of Significant Accoun36

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Total common stock equivalents outstanding	468,320	198,334
Options [Member]
Total common stock equivalents outstanding	15,340	31,530
Common Stock Warrants [Member]
Total common stock equivalents outstanding	222,222	155,108
Convertible Preferred Stock [Member]
Total common stock equivalents outstanding	147,901
Convertible Secured Debentures [Member]
Total common stock equivalents outstanding	82,857	11,696

Fair Value (Details Narrative)

Fair Value (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Fair value assumptions, expected dividend payments	$ 0
Impairment charges		$ 806,716

Fair Value - Schedule of Fair V

Fair Value - Schedule of Fair Value on Recurring and Nonrecurring Basis (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Derivative liability		$ 7,700,585
Fair Value, Inputs, Level 1 [Member]
Derivative liability
Fair Value, Inputs, Level 2 [Member]
Derivative liability
Fair Value, Inputs, Level 3 [Member]
Derivative liability		7,700,585
Warrant Liability [Member]
Derivative liability		7,195,617
Warrant Liability [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative liability
Warrant Liability [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative liability
Warrant Liability [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative liability		7,195,617
Embedded Conversion Feature [Member]
Derivative liability		504,968
Embedded Conversion Feature [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative liability
Embedded Conversion Feature [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative liability
Embedded Conversion Feature [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative liability		$ 504,968

Fair Value - Schedule of Fair39

Fair Value - Schedule of Fair Value on Recurring Basis Using Significant Unobservable Inputs (level 3) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Balance - Beginning	$ 7,700,585	$ 1,241,841
Change in fair value	(2,255,322)	(370,626)
Warrants issued in connection with debt transactions		1,000,000
Excess fair value of warrants issued over related debt		5,591,371
Reclassification of equity instruments to derivative liabilities due to tainting of warrants		5,396,350
Reclassification of derivative liabilities to equity from the exercise of warrants and issuance of shares for convertible debt		5,086,351
Reclassifications of derivative liabilities to equity	(427,568)
Derivative extinguishment	(5,017,695)
Balance - Ending		7,700,585
Warrant Liability [Member]
Balance - Beginning	7,195,617	1,241,841
Change in fair value	(2,131,990)	(386,182)
Warrants issued in connection with debt transactions		446,588
Loss on modification of warrants		2,622,080
Excess fair value of warrants issued over related debt		2,879,291
Reclassification of equity instruments to derivative liabilities due to tainting of warrants		5,396,350
Reclassification of derivative liabilities to equity from the exercise of warrants and issuance of shares for convertible debt		(5,022,351)
Reclassifications of derivative liabilities to equity	(396,854)
Derivative extinguishment	(4,666,773)
Balance - Ending		7,195,617
Embedded Conversion Feature [Member]
Balance - Beginning	504,968
Change in fair value	(123,332)	15,556
Warrants issued in connection with debt transactions		553,412
Excess fair value of warrants issued over related debt
Reclassification of equity instruments to derivative liabilities due to tainting of warrants
Reclassification of derivative liabilities to equity from the exercise of warrants and issuance of shares for convertible debt		(64,000)
Reclassifications of derivative liabilities to equity	(30,714)
Derivative extinguishment	(350,922)
Balance - Ending		$ 504,968

Fair Value - Schedule of Fair40

Fair Value - Schedule of Fair Value on Recurring and Nonrecurring Valuation Techniques (Details)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Dividends	0.00%	0.00%
Minimum [Member]
Risk free interest rate	0.20%	0.20%
Expected term	2 months 30 days	2 months 30 days
Volatility	62.00%	51.00%
Maximum [Member]
Risk free interest rate	1.94%	2.25%
Expected term	7 years 26 days	7 years 2 months 30 days
Volatility	142.00%	123.00%

Inventory, Net - Schedule of In

Inventory, Net - Schedule of Inventory (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Inventory Disclosure [Abstract]
Production materials consumables, spare parts, and accessories	$ 738,950	$ 937,133
Work in process		853,800
Total at cost	738,950	1,790,933
Slow moving inventory allowance		(175,000)
Inventory, net	$ 738,950	$ 1,615,933

Property and Equipment, Net (De

Property and Equipment, Net (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 616,480	$ 599,992
Production cost per unit		631,000
Loss on disposal of property and equipment		$ 1,049,000

Property and Equipment, Net - S

Property and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Property and Equipment, Gross	$ 8,897,654	$ 7,877,875
Accumulated depreciation and amortization	(2,032,265)	(1,474,944)
Property and Equipment, Net	$ 6,865,389	6,402,931
Minimum [Member]
Estimated useful life	3 years
Maximum [Member]
Estimated useful life	39 years 6 months
Machinery and Equipment [Member]
Property and Equipment, Gross	$ 482,263	400,106
Machinery and Equipment [Member] | Minimum [Member]
Estimated useful life	3 years
Machinery and Equipment [Member] | Maximum [Member]
Estimated useful life	5 years
Furniture and Office Equipment [Member]
Property and Equipment, Gross	$ 182,305	179,206
Furniture and Office Equipment [Member] | Minimum [Member]
Estimated useful life	5 years
Furniture and Office Equipment [Member] | Maximum [Member]
Estimated useful life	7 years
Transportation [Member]
Property and Equipment, Gross	$ 222,144	303,826
Transportation [Member] | Minimum [Member]
Estimated useful life	3 years
Transportation [Member] | Maximum [Member]
Estimated useful life	5 years
Production Units [Member]
Property and Equipment, Gross	$ 4,910,736	4,757,896
Production Units [Member] | Minimum [Member]
Estimated useful life	5 years
Production Units [Member] | Maximum [Member]
Estimated useful life	30 years
Building [Member]
Property and Equipment, Gross	$ 2,237,257	2,236,841
Estimated useful life	39 years 6 months
Parts [Member]
Property and Equipment, Gross	$ 862,949
Estimated useful life	0 years

Intangible Assets, Net (Details

Intangible Assets, Net (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense of intangible assets	$ 55,894	$ 55,895

Intangible Assets, Net - Schedu

Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Intellectual property	$ 869,502	$ 838,398
Less: Accumulated amortization	(457,171)	(401,277)
Intangible assets, net	$ 412,331	$ 437,121
Estimated useful life	15 years

Intangible Assets, Net - Sche46

Intangible Assets, Net - Schedule of Future Amortization Expense (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
2,018	$ 58,014
2,019	58,014
2,020	58,014
2,021	58,014
2,022	58,014
Thereafter	122,261
Total	$ 412,331	$ 437,121

Investments in Joint Ventures47

Investments in Joint Ventures (Details Narrative) - USD ($)	Mar. 19, 2014	Jun. 28, 2010	Jun. 25, 2010
Magnegas corporation's common stock exchanged to purchase the interest in magnegas europe			250,000
Ownership interest			20.00%
Company valued the investment in the joint venture at the fair market value of the shares issued			$ 23,750
Share of subsidiary given to party in addition to agreement exchange price		20.00%
Company's investment for technology license		$ 466,660
Debt instrument, description	Under the terms of the agreement, both parties will own 50%
Investment in Joint Ventures [Member]
Ownership interest	50.00%
Investment in Joint Ventures [Member] | Confidential Partner [Member]
Investment of company for research and development and research activity	$ 254,840

Investments in Joint Ventures -

Investments in Joint Ventures - Schedule of Investments in Joint Ventures (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Additional investments during 2016		$ 52,115
Investment in joint ventures gross	$ 806,716	806,716
Less impairment	(806,716)	(806,716)
Investment in joint ventures , Total			$ 754,601
MagneGas Europe [Member]
Investment in joint ventures , Total			23,750
MagneGas China [Member]
Investment in joint ventures , Total			466,660
Future Energy Pty Ltd. [Member]
Investment in joint ventures , Total			229,840
Other [Member]
Investment in joint ventures , Total			$ 34,351

Capitalized Leases (Details Nar

Capitalized Leases (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Leases [Abstract]
Capital lease expiration period, description	The Company has equipment under various capital leases expiring in July 2020, October 2020, August 2022 and September 2022.
Capital lease asset, gross	$ 91,299	$ 34,645
Capital lease asset, accumulated amortization	$ 22,725	$ 11,036
Capital lease obligation, interest rate	6.00%

Capitalized Leases - Schedule o

Capitalized Leases - Schedule of Future Minimum Lease Payments for Capital Leases (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Leases [Abstract]
2,018	$ 27,460
2,019	27,460
2,020	24,791
2,021	18,132
2,022	5,064
Total minimum lease payments	102,907
Less amount representing interest	11,608
Present value of minimum lease payments	91,299
Less current portion of minimum lease	27,460	$ 9,328
Long-term present value of minimum lease payment	$ 63,839

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Nov. 30, 2017	Nov. 15, 2017	Aug. 21, 2017	May 09, 2017	Apr. 11, 2017	Apr. 03, 2017	Jun. 27, 2016	May 09, 2017	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2017	Dec. 31, 2016
Warrants to purchase common stock							35,088
Warrant exercise price							$ 1.50					$ 1.50
Proceeds from issuance of warrant							$ 2,540,821					$ 2,540,821
Warrant term							6 months
Liquidating damages, percentage							2.00%
Investments							$ 80,000
Debt discount							1,000,000
Fair value of warrants							6,675,000					2,622,080
Interest expenses							$ 2,622,080
Amortization of debt discount											1,030,372	$ 189,000
Stock issued during period, shares												1,333
Stock issued for settlement of debt, shares								6,667				134,000
Stock issued for settlement of debt								$ 57,000				$ 886,000
Beneficial conversion amount												829,000
Extinguishment of Debt											(513,725)
Fair value of derivative liabilities									$ 427,568	$ 427,568	427,568
Proceeds from sale of personal property and equipment											121,343	$ 20,450
Settlement Agreement [Member]
Debt discount									829,000	829,000	829,000
Short Term Note Agreement [Member]
Note interest rate		25.00%
Debt Instrument, Periodic Payment, Principal		$ 10,417
Debt principal amount									750,000	750,000	$ 750,000
Proceeds from short term debt		$ 500,000
Agreement term		12 months									12 months
Balloon payment to be paid		$ 625,000
Commitment fees		$ 125,000									$ 250,000
Accreted discount									65,796	65,796	65,796
Loss on settlement of senior debenture											121,428
Convertible Debentures [Member]
Note interest rate							0.00%
Note due date							Jun. 30, 2021
Debt principal amount				$ 829,000			$ 1,000,000	829,000
Beneficial conversion, percentage							9.99%
Debt discount				$ 829,000				$ 829,000
Stock issued during period, shares				153,048
Debt conversion price per share							$ 85.50
Number of common stock shares convertible				8,726
Debt premium rate				10.00%				10.00%
Increase in extinguishment percentage				10.00%
Extinguishment of Debt				$ 513,725
Fair value of derivative liabilities									427,568	427,568	427,568
Convertible Debentures [Member] | Minimum [Member]
Debt conversion price per share				$ 85.50				$ 85.50
Convertible Debentures [Member] | Maximum [Member]
Debt conversion price per share				$ 45				$ 45
NoteHolder [Member]
Debt discount									800,000	$ 800,000	800,000
Number of common stock shares convertible										152,381
NoteHolder [Member] | Settlement Agreement [Member]
Debt principal amount	$ 602,970
Stock issued for settlement of debt, shares	106,667
Stock issued for settlement of debt	$ 29,000
Senior Debentures [Member]
Note interest rate				8.00%				8.00%
Note due date				Nov. 30, 2017
Debt principal amount				$ 1,000,000				$ 1,000,000
Debt discount									0	$ 0	0
Debt issuance cost									60,000	60,000	60,000
Debt expenses											60,000
Board of Directors [Member]
Note payable related party						$ 50,000
Note interest rate						15.00%
Note due date						Jul. 3, 2017
Board of Directors [Member] | First Quarter of 2018 [Member]
Debt Instrument, Periodic Payment, Principal						$ 35,000
Debt instrument interest						$ 6,313
Chief Executive Officer [Member]
Note payable related party					$ 50,000
Note interest rate					15.00%
Note due date					Jul. 11, 2017
Payments to fund to related parties			$ 7,103
Due to related party									182,070	$ 182,070	$ 182,070
Chief Executive Officer [Member] | Accrued Expenses Related Parties [Member]
Amount funded to working capital									$ 249,570
Chief Executive Officer [Member] | First Quarter of 2018 [Member]
Debt Instrument, Periodic Payment, Principal					$ 20,000
Debt instrument interest					$ 6,146

Notes Payable - Schedule of War

Notes Payable - Schedule of Warrants to Purchase Common Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Jun. 27, 2016
Common stock warrants			35,088
Exercise price		$ 1.50	$ 1.50
Warrants One [Member]
Common stock warrants	23,392
Exercise price	$ 157.50
Expiration date	12/23/2023
Warrants Two [Member]
Common stock warrants	11,696
Exercise price	$ 195
Expiration date	12/23/2023
Warrants Three [Member]
Common stock warrants	46,784
Exercise price	$ 151.50
Expiration date	12/31/2016
Warrants Four [Member]
Common stock warrants	23,392
Exercise price	$ 157.50
Expiration date	12/27/2023
Warrants Five [Member]
Common stock warrants	11,696
Exercise price	$ 195
Expiration date	12/27/2023

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Sep. 15, 2017	Jul. 27, 2017	Jul. 21, 2017	Jul. 21, 2017	Jun. 15, 2017	Jun. 12, 2017	May 18, 2017	May 09, 2017	May 09, 2017	Jun. 27, 2016	May 09, 2017	Dec. 31, 2017	Dec. 31, 2016	Jun. 14, 2017
Stockholders' equity, reverse stock split							one-for-ten reverse split
Common stock, shares authorized												190,000,000	190,000,000
Number of common stock issued during period, shares													1,333
Number of common stock issued during period, value													$ 2,785,287
Warrants exercisable term													1 year
Warrants exercisable price per share										$ 1.50			$ 1.50
Reclassified fair value of warrants													$ 7,195,617
Common shares issued for services, shares													10,992
Common shares issued for services, value												$ 2,971,465	$ 1,109,500
Shares issued to settled outstanding liabilities												13,333
Shares issued to settled outstanding liabilities, value												$ 48,201
Loss on settlement of liabilities												$ 11,715
Stock issued for settlement of debt, shares											6,667		134,000
Stock issued for settlement of debt											$ 57,000		$ 886,000
Common stock issued for exercise of warrants, shares												5,291	63,810
Proceeds from exercise of warrants												$ 7,937	$ 95,714
Derivative liability													$ 7,700,585
Common stock issued for conversion of debt, shares													1,333
Common stock issued for conversion of debt, shares, value												$ 857,000	$ 114,000
Embedded conversion feature													$ 829,000
Preferred stock stated value												$ 0.001	$ 0.001
Fair value of warrants										$ 6,675,000			$ 2,622,080
Loss on extinguishment of debt												(513,725)
Derivative extinguishment												$ 5,017,695
Convertible preferred stock shares issued upon conversion						8,555,556
Warrant term										6 months
Preferred stock shares authorized												10,000,000	10,000,000
Maxim Group, LLC [Member]
Warrants exercisable term												5 years
Warrants exercisable price per share												$ 49.50
Warrant term												5 years
Cash payable on gross proceeds, percentage												6.00%
Cash fees												$ 4,050
Legal expense reimbursement												$ 5,000
Securities Purchase Agreement [Member]
Preferred stock shares issued						75
Shares issued price per share						$ 900
Series A Preferred Stock [Member]
Preferred stock shares designated												1,000,000	1,000,000
Preferred stock shares issued												1,000,000	1,000,000
Preferred stock shares outstanding												1,000,000	1,000,000
Preferred stock shares voting rights												The Series A Preferred Stock does not have any conversion provision or provides for cumulative dividends and each share of Series A Preferred Stock has voting rights equal to 667 shares of common stock.	The Series A Preferred Stock does not have any conversion provision or provides for cumulative dividends and each share of Series A Preferred Stock had voting rights equal to 667 shares of common stock.
Preferred stock stated value												$ 0.001	$ 0.001
Preferred stock aggregate value												$ 1,000	$ 1,000
Preferred stock shares authorized												1,000,000	1,000,000
Series C Preferred Stock [Member] | Alternate Conversion Price Three [Member]
Preferred stock conversion terms					The Company may, at its option following notice to each holder, redeem such amount of Preferred Shares by paying to each holder the corresponding installment amount in cash. The applicable installment conversion price with respect to a particular date of determination, shall be equal to the lower of (A) the conversion price then in effect and (B) the greater of (x) $5.25 and (y) the lower of (i) 85% of the VWAP of the common stock as of the trading day immediately preceding the applicable Installment Date and (ii) 85% of the quotient of (A) the sum of the VWAP of the common stock for each of the ten (10) trading days with the lowest VWAP of the common stock during the twenty (20) consecutive trading day period ending and including the trading day immediately prior to the applicable Installment Date, divided by (B) ten (10).
Common Stock Warrants [Member]
Intrinsic value of warrants outstanding												$ 0	$ 0
Intrinsic value of warrants exercisable												0	0
Preferred Stock Warrants [Member]
Intrinsic value of warrants outstanding												0	0
Intrinsic value of warrants exercisable												$ 0	$ 0
Convertible Note [Member]
Common stock issued for conversion of debt, shares												667
Common stock issued for conversion of debt, shares, value												$ 57,000
Embedded conversion feature												$ 30,717
Advisors and Consultants [Member]
Common shares issued for services, shares												250,331
Common shares issued for services, value												$ 3,181,167
Common Stock One [Member]
Number of common stock issued during period, shares													6,803
Number of shares converted into common stock												36,011
Warrants [Member]
Number of common stock issued during period, shares													5,291
Derivative liability												$ 396,854	$ 5,022,351
Common Stock [Member]
Number of common stock issued during period, shares													6,803
Number of common stock issued during period, value													$ 7
Common shares issued for services, shares												203,666	10,992
Common shares issued for services, value												$ 204	$ 11
Loss on settlement of liabilities												$ 631,970
Stock issued for settlement of debt, shares												106,667
Stock issued for settlement of debt												$ 29,000
Common stock issued for conversion of debt, shares												153,048
Common stock issued for conversion of debt, shares, value												$ 153
Conversion of stock, shares converted												120,100
Common Stock [Member] | Exchange Agreement [Member]
Conversion of stock, shares converted								66,667
Series B Preferred Stock [Member]
Number of common stock issued during period, shares									2,700
Preferred stock shares designated								2,700	2,700		2,700
Conversion of stock, shares converted price per share								$ 45	$ 45		$ 45
Conversion of stock, shares converted									66,667
Number of warrants cancelled								1,479,904	1,479,904		1,479,904
Fair value of warrants									$ 4,666,773
Conversion of stock shares converted, value									5,652,500
Beneficial conversion feature, amount									350,922
Debt instrument outstanding principal amount								$ 829,000	$ 829,000		$ 829,000
Convertible preferred stock shares issued upon conversion								187,263	187,263		187,263
Debt instrument interest rate percentage									10.00%
Series B Preferred Stock [Member] | Exchange Agreement [Member]
Number of common stock issued during period, shares									2,700
Number of common stock issued during period, value									$ 1,000
Conversion of stock, shares converted price per share								$ 45	$ 45		$ 45
Warrants exercisable									1,479,904
Preferred stock stated value								$ 1,000	$ 1,000		$ 1,000
Conversion of stock, shares converted									60,000
Series B Convertible Preferred Stock One [Member]
Conversion of stock, shares converted price per share												$ 45
Conversion of stock, shares converted												2,700
Loss on extinguishment of debt												$ 513,725
Convertible preferred stock shares issued upon conversion												60,000
Series C Preferred Stock [Member]
Preferred stock shares designated					25,000
Conversion of stock, shares converted price per share					$ 45
Preferred stock stated value					$ 1,000
Preferred stock dividend percentage					18.00%
Preferred stock redemption amount, percentage					103.00%
Series C Preferred Stock [Member] | Alternate Conversion Price One [Member]
Preferred stock conversion terms					The lower of (A) the applicable conversion price as then in effect and (B) the greater of (x) $5.25 and (y) the lowest of (i) 85% of the Value Weighted Average Price (“VWAP”) of the common stock as of the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, (ii) 85% of the VWAP of the common stock as of the trading day of the delivery or deemed delivery of the applicable conversion notice and (iii) 85% of the price computed as the quotient of (I) the sum of the VWAP of the common stock for each of the ten (10) trading days with the lowest VWAP of the common stock during the twenty (20) consecutive trading day period ending and including the trading day immediately preceding the delivery or deemed delivery of the applicable conversion notice, divided by (II) ten (10).
Series C Preferred Stock [Member] | Alternate Conversion Price Two [Member]
Preferred stock conversion terms					In lieu of conversion, upon a triggering event, the holder may require the Company to redeem all or any of the Preferred Shares at a price equal to the greater of (i) the product of (A) the conversion amount of the Preferred Shares to be redeemed multiplied by (B) a redemption premium of 115% and (ii) the product of (X) the conversion rate with respect to the conversion amount in effect at such time of redemption multiplied by (Y) the product of (1) a redemption premium of 115% multiplied by (2) the greatest closing sale price of the common stock on any trading day during the period commencing on the date immediately preceding such Triggering Event and ending on the date the Company makes the entire redemption payment.
Series C Preferred Stock [Member] | Securities Purchase Agreement [Member]
Number of common stock issued during period, shares						25,000,000
Series C Convertible Preferred Warrants [Member] | Securities Purchase Agreement [Member]
Number of common stock issued during period, shares						25,000,000
Series C Convertible Preferred Warrants [Member] | Warrant Holder [Member]
Number of warrants exercised												3,528
Common Stock Purchase Warrants [Member] | Securities Purchase Agreement [Member]
Number of common stock issued during period, shares						25,000,000
Preferred Warrants [Member]
Warrants exercisable price per share						$ 900
Warrants exercisable						24,925
Common Stock Warrants [Member]
Warrants exercisable term						5 years
Warrants exercisable price per share						$ 45
Common stock issued for exercise of warrants, shares												5,291
Proceeds from exercise of warrants												$ 7,937
Warrants exercisable						194,444
Common stock conversion features description						The Common Stock Warrants are exercisable for 194,444 shares of common stock, representing thirty-five percent (35%) of the total number of shares of common stock initially issuable upon conversion of the Preferred Shares.
Series C Convertible Preferred Shares [Member] | Warrant Holder [Member]
Conversion of stock, shares converted												3,413
Number of warrants exercised												3,528
Preferred Stock [Member]
Preferred stock stated value	$ 1.36
Preferred Stock [Member] | Warrant Holder [Member]
Preferred stock shares issued												75
Conversion of stock shares converted, value												$ 3,413,000
Number of shares converted into common stock												634,482
Preferred Stock [Member] | Warrant Holder [Member] | Series C Preferred Stock [Member]
Beneficial conversion feature, amount												$ 3,528,000
Series C Convertible Preferred Stock [Member]
Preferred stock shares outstanding												115
Preferred stock outstanding value												$ 115,000
Series D Convertible Preferred Stock Warrants [Member]
Conversion of stock, shares converted price per share			$ 15	$ 15
Preferred stock stated value			$ 0.001	$ 0.001
Preferred stock dividend percentage			18.00%
Preferred stock conversion terms			In addition, under the Series D Convertible Preferred Stock designation holders representing at 65% of the aggregate stated value amount of the Preferred Shares then outstanding shall be required for any change, waiver or amendment to the certificate of designations provided, that 65% must include the holders as long as they beneficially owns any preferred shares.
Preferred stock redemption amount, percentage			75.00%
Preferred stock shares authorized			694,222	694,222
Series D Convertible Preferred Stock Warrants [Member] | One of More Investors [Member] | Securities Purchase Agreement [Member]
Number of common stock issued during period, shares		10,000		10,000
Warrants exercisable price per share		$ 1	$ 1	$ 1
Proceeds from exercise of warrants				$ 826,182
Conversion of stock, shares converted price per share		$ 15
Warrants exercisable		694,422
Preferred stock stated value			15	$ 15
Conversion of stock shares converted, value		$ 826,182
Convertible preferred stock shares issued upon conversion		46,295
Warrant term				2 years 5 months 5 days
Common stock conversion price per share		$ 13.17	$ 15	$ 15
Series D Convertible Preferred Stock [Member]
Conversion of stock, shares converted price per share												$ 5.85
Conversion of stock, shares converted												694,422
Series D-1 Convertible Preferred Stock [Member]
Preferred stock shares designated													1,060
Preferred stock stated value													$ 0.001
Conversion of stock shares converted, value													$ 1,500
Series D-2 Convertible Preferred Stock [Member]
Preferred stock shares designated													940
Conversion of stock, shares converted price per share													$ 0.001
Conversion of stock shares converted, value													$ 1,500
Series E Convertible Preferred Stock [Member]
Warrants exercisable price per share												$ 1.36
Preferred stock shares outstanding												316,875
Conversion of stock, shares converted price per share	1.36
Preferred stock stated value	$ 0.001
Conversion of stock, shares converted	455,882
Conversion of stock shares converted, value												$ 189,049
Beneficial conversion feature, amount												$ 620,000
Convertible preferred stock shares issued upon conversion												36,765
Common stock conversion features description	In addition, under the Series E Convertible Preferred Stock designation holders representing at 65% of the aggregate stated value amount of the Preferred Shares then outstanding shall be required for any change, waiver or amendment to the certificate of designations provided, that 65% must include the holders as long as they beneficially owns any preferred shares.
Preferred stock conversion terms	At any time after the occurrence of a triggering event the holder may, at its option, convert the Series E Convertible Preferred Stock under an alternate conversion price which is the lower of the applicable conversion price in effect on the applicable conversion date of the applicable alternate conversion and the greater of the following:
Preferred stock redemption amount, percentage	75.00%
Number of warrants exercised												419,117
Proceeds from stock issuance cost												$ 5,000
Warrant term												2 years 3 months 11 days
Number of shares converted into common stock												139,007
Cash proceeds												$ 0
Preferred stock outstanding value	$ 547,351
Preferred outstanding stated value												$ 430,950
Series E Convertible Preferred Warrants [Member] | Warrant Holder [Member]
Number of warrants exercised												419,117
Proceeds from stock issuance cost												$ 569,999
Series E Convertible Preferred Shares [Member] | Warrant Holder [Member]
Number of warrants exercised												419,117
Proceeds from stock issuance cost												$ 569,999
Options [Member]
Fair value of non-vested options												$ 446,183
Non-vested options weighted average remaining term												1 year 6 months 30 days
2014 Equity Incentive Award Plan [Member]
Number of shares issued upon exercise of outstanding options, warrants and rights												15,432
Number of remaining shares available for future issuance												784.3
Minimum [Member]
Common stock, shares authorized														90,000,000
Maximum [Member]
Common stock, shares authorized														190,000,000
January 16, 2018 [Member]
Stockholders' equity, reverse stock split												A one-for-fifteen reverse split of the Company’s issued and outstanding common stock (the “2018 Reverse Stock Split”),

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Options Outstanding (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Option Outstanding, Balance Beginning	32,508	28,473
Option Outstanding, Granted		4,035
Option Outstanding, Exercised
Option Outstanding, Forfeited
Option Outstanding, Expired	(17,166)
Option Outstanding, Balance Ending	15,342	32,508
Option Outstanding, Exercisable	15,342
Weighted Average Exercise Price, Beginning Balance	$ 93.54	$ 198
Weighted Average Exercise Price, Granted		93
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited
Weighted Average Exercise Price, Expired	34.73
Weighted Average Exercise Price, Ending Balance	$ 159.34	$ 93.54
Weighted Average Remaining Life in Years Beginning	1 year 2 months 24 days	2 years 4 months 25 days
Weighted Average Remaining Life in Years Ending	1 year 6 months 30 days	5 years
Intrinsic Value, Outstanding Beginning	$ 14	$ 968,000
Intrinsic Value, Outstanding Ending	$ 0	$ 14

Stockholders' Equity - Schedu55

Stockholders' Equity - Schedule of Stock Options Valuation Assumptions (Details)	12 Months Ended
	Dec. 31, 2016
Risk free interest rate	1.10%
Volatility	55.60%
Dividends	0.00%
Minimum [Member]
Expected term	3 years
Maximum [Member]
Expected term	5 years

Stockholders' Equity - Schedu56

Stockholders' Equity - Schedule of Warrants Outstanding (Details) - $ / shares	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Common Stock Warrant [Member]
Warrants Outstanding, Beginning Balance	153,282	51,352
Warrants Outstanding, Granted	22,222	186,061
Warrants Outstanding, Exercised	(5,291)	(63,810)
Warrants Outstanding, Forfeited/Exchanged
Warrants Outstanding, Expired	(147,991)	(20,321)
Warrants Outstanding, Ending Balance	22,222	153,282
Warrants Outstanding, Exercisable	22,222
Weighted Average Exercise Price, Beginning Balance	$ 136.50	$ 199.50
Weighted Average Exercise Price, Granted	455.63	82.50
Weighted Average Exercise Price, Exercised	15	1.50
Weighted Average Exercise Price, Forfeited/Exchanged
Weighted Average Exercise Price, Expired	136.50
Weighted Average Exercise Price, Ending Balance	$ 455.63	$ 136.50
Weighted Average Remaining Life in Years, Beginning	5 years 9 months 18 days
Weighted Average Remaining Life in Years, Granted	5 years
Weighted Average Remaining Life in Years, Ending	4 years 5 months 12 days	5 years 9 months 18 days
Preferred Stock Warrant [Member]
Warrants Outstanding, Beginning Balance
Warrants Outstanding, Granted	24,925
Warrants Outstanding, Exercised	(3,528)
Warrants Outstanding, Forfeited/Exchanged
Warrants Outstanding, Expired
Warrants Outstanding, Ending Balance	21,397
Warrants Outstanding, Exercisable	21,397
Weighted Average Exercise Price, Beginning Balance
Weighted Average Exercise Price, Granted	9
Weighted Average Exercise Price, Exercised	9
Weighted Average Exercise Price, Forfeited/Exchanged
Weighted Average Exercise Price, Ending Balance	$ 9
Weighted Average Remaining Life in Years, Beginning	0 years
Weighted Average Remaining Life in Years, Granted	5 years
Weighted Average Remaining Life in Years, Ending	4 years 5 months 12 days

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	12 Months Ended
	Dec. 31, 2017USD ($)ft²	Dec. 31, 2016USD ($)
Area of land | ft²	5,000
Rent payable	$ 4,000
Rent expense	$ 12,000	$ 48,000
EcoPlus, Inc. [Member]
Common stock, voting rights	The lease was held by EcoPlus, Inc., a company that is effectively controlled by Dr. Ruggero Santilli, a former officer and director of the Company and one of the people who currently has voting and investment control over 1,000,000 shares of Series A Preferred Stock which, in turn, has 100,000 votes per share on any matters brought to a vote of the common stock shareholders.
Lease termination date	May 27, 2017

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	Apr. 16, 2015USD ($)
Commitments and Contingencies Disclosure [Abstract]
Litigation settlement	$ 52,000

Income Tax (Details Narrative)

Income Tax (Details Narrative) - USD ($)	Dec. 22, 2017	Dec. 22, 2017	Dec. 31, 2017	Dec. 31, 2016
Deferred tax assets at the federal rate	34.00%		0.00%	0.00%
Income tax examination, description			The Company’s gross deferred tax assets have been revalued from 35% to 21% with a corresponding offset to the valuation allowance and any potential other taxes arising due to the Tax Act will result in reductions to its net operating loss carryforward and valuation allowance.
Deferred tax assets			$ 24,700,000
Deferred tax assets, revalued			15,000,000
Change in valuation allowance			590,000
Tax Reform Bill [Member]
Deferred tax assets at the federal rate		21.00%
Income tax examination, description		Prior to the enactment of the Tax Reform Bill, the Company measured its deferred tax assets at the federal rate of 34%. The Tax Reform Bill reduced the federal tax rate to 21% resulting in the re-measurement of the deferred tax asset as of December 31, 2017. Beginning January 1, 2018, the lower tax rate of 21% will be used to calculate the amount of any federal income tax due on taxable income earned during 2018.
Federal Tax Authority [Member]
Operating Loss Carryforwards			54,536,000	$ 42,374,000
State and Local Jurisdiction [Member]
Operating Loss Carryforwards			$ 42,374,000	$ 54,536,000

Income Tax - Schedule of Compon

Income Tax - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
U.S. federal: Current
U.S. federal: Deferred	3,160,000	(3,900,000)
State and local: Current
State and local: Deferred	(1,000,000)	(400,000)
Total	(2,160,000)	(4,300,000)
Change in valuation allowance	4,890,000	4,300,000
Income Tax Provision

Income Tax - Schedule of Effect

Income Tax - Schedule of Effective Income Tax Rate Reconciliation (Details)	Dec. 22, 2017	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
U.S. federal statutory rate		34.00%	34.00%
State income taxes, net of federal benefit		4.22%	2.41%
Other permanent items		4.71%	(10.41%)
Effect of federal tax rate change		(66.96%)	(1.46%)
Effect of state tax rate change		3.76%
Change in valuation allowance		20.27%	(24.55%)
Effective rate	34.00%	0.00%	0.00%

Income Tax - Schedule of Deferr

Income Tax - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Deferred tax assets: Net Operating Loss carryover	$ 14,400,000	$ 16,000,000
Deferred tax assets: Stock-based compensation	600,000	900,000
Deferred tax assets: Other		600,000
Total deferred tax asset	15,000,000	17,300,000
Less reserve for allowance	15,000,000	17,300,000
Total Deferred tax asset net of valuation allowance

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 03, 2018	Mar. 13, 2018	Feb. 16, 2018	Jan. 19, 2018	Apr. 11, 2018	Apr. 02, 2018	Dec. 31, 2017	Dec. 31, 2016	Jun. 25, 2010
Prepaid related party debt							$ 7,103
Granted of time-vested common stock options								4,035
Payment to acquire assets							$ 250,252	$ 1,445,855
Ownership percentage									20.00%
Common Stock [Member]
Conversion of shares into stock							120,100
Subsequent Event [Member]
Prepaid related party debt						$ 67,458
Subsequent Event [Member] | Santilli Employment Agreement [Member]
Granted of time-vested common stock options		100,000
Common stock options vested		50,000
Remaining common stock option vested to vest		50,000
Subsequent Event [Member] | Mahoney Employment Agreement [Member]
Granted of time-vested common stock options		100,000
Common stock options vested		50,000
Remaining common stock option vested to vest		50,000
Subsequent Event [Member] | Asset Purchase Agreement [Member] | GGNG Enterprises Inc. [Member]
Payment to acquire assets				$ 350,000
Total purchase price				$ 745,000
Subsequent Event [Member] | Asset Purchase Agreement [Member] | Green Arc Supply, L.L.C. [Member]
Purchased assets and assumed liabilities, net			$ 2,500,000
Cash payment			1,000,000
Issuance of number of shares of restricted common stock			$ 1,500,000
Subsequent Event [Member] | Chief Executive Officer [Member] | Santilli Employment Agreement [Member]
Officers compensation		$ 235,000
Subsequent Event [Member] | Chief Financial Officer [Member] | Mahoney Employment Agreement [Member]
Officers compensation		$ 215,000
Subsequent Event [Member] | Sellers [Member] | Securities Purchase Agreement Execution [Member]
Gross purchase price of capital stock purchase	$ 1,000,000
Subsequent Event [Member] | Sellers [Member] | Securities Purchase Agreement [Member]
Ownership percentage	100.00%
Gross purchase price of capital stock purchase	$ 2,000,000
Subsequent Event [Member] | Series C Convertible Preferred Warrants [Member] | Warrant Holder [Member]
Number of warrants exercised					9,991
Subsequent Event [Member] | Series C Convertible Preferred Shares [Member] | Common Stock [Member]
Conversion of shares into stock					9,150,370
Subsequent Event [Member] | Series C Convertible Preferred Shares [Member] | Warrant Holder [Member]
Number of warrants exercised					9,991
Subsequent Event [Member] | Series C Convertible Preferred Shares [Member] | Investor [Member]
Conversion of shares into stock					9,550
Subsequent Event [Member] | Preferred Warrants [Member] | Warrant Holder [Member]
Number of warrants exercised					0
Subsequent Event [Member] | Series E Preferred Shares [Member] | Common Stock [Member]
Conversion of shares into stock					135,754
Subsequent Event [Member] | Series E Preferred Shares [Member] | Warrant Holder [Member]
Number of warrants exercised					0
Subsequent Event [Member] | Series E Preferred Shares [Member] | Investor [Member]
Conversion of shares into stock					280,111